RxNorm Semantic Concepts Index - 154
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "154".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 154 | Nicoumalone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 154 | Nicoumalone | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 154 | Nicoumalone | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 154 | Nicoumalone | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 154 | Nicoumalone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 154 | Nicoumalone | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1540 | bile salts | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1540 | bile salts | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1540 | bile salts | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1540019 | Broncomar Expectorant | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1540020 | guaiFENesin 20 MG/ML [Broncomar Expectorant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1540020 | guaiFENesin 20 MG/ML [Broncomar Expectorant] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1540021 | guaiFENesin Oral Solution [Broncomar Expectorant] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1540021 | guaiFENesin Oral Solution [Broncomar Expectorant] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1540022 | Broncomar Expectorant Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1540023 | Broncomar Expectorant Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1540024 | Broncomar SF Expectorant 100 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1540024 | Broncomar SF Expectorant 100 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1540024 | Broncomar SF Expectorant 100 MG in 5 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1540024 | Broncomar SF Expectorant 100 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1540025 | Eucalyptus camaldulensis leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1540026 | Lincobac | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1540027 | lincomycin 300 MG/ML [Lincobac] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1540028 | lincomycin Injectable Solution [Lincobac] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1540029 | Lincobac Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1540030 | lincomycin 300 MG/ML Injectable Solution [Lincobac] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1540030 | lincomycin 300 MG/ML Injectable Solution [Lincobac] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1540045 | tiludronic acid 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1540046 | tiludronic acid Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1540047 | tiludronic acid Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1540048 | tiludronic acid 20 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1540048 | tiludronic acid 20 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1540049 | tiludronic acid 20 MG/ML [Tildren] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1540050 | tiludronic acid Injectable Solution [Tildren] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1540051 | Tildren 20 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1540051 | Tildren 20 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1540051 | Tildren 20 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1540051 | Tildren 20 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1540206 | Quellin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1540207 | carprofen 100 MG [Quellin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1540208 | carprofen Chewable Tablet [Quellin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1540209 | Quellin Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1540210 | Quellin Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1540211 | Quellin Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1540212 | quellin 100 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1540212 | quellin 100 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1540212 | quellin 100 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1540213 | carprofen 25 MG [Quellin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1540214 | quellin 25 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1540214 | quellin 25 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1540214 | quellin 25 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1540215 | carprofen 75 MG [Quellin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1540216 | quellin 75 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1540216 | quellin 75 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1540216 | quellin 75 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1540219 | Fungazoil | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1540220 | clotrimazole 10 MG/ML [Fungazoil] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1540221 | clotrimazole Topical Solution [Fungazoil] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1540222 | Fungazoil Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1540223 | FungaZoil 1 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1540223 | FungaZoil 1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1540223 | FungaZoil 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1540223 | FungaZoil 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1540225 | ketorolac 2.88 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1540226 | phenylephrine 10.16 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1540229 | Product containing ketorolac and phenylephrine (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 1540229 | Product containing ketorolac and phenylephrine (medicinal product) | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1540229 | Product containing ketorolac and phenylephrine (medicinal product) | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1540230 | phenylephrine 1 % / ketorolac 0.3 % Concentrate for Ophthalmic Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1540230 | phenylephrine 1 % / ketorolac 0.3 % Concentrate for Ophthalmic Irrigation Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1540230 | phenylephrine 1 % / ketorolac 0.3 % Concentrate for Ophthalmic Irrigation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1540231 | Omidria | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1540232 | ketorolac 2.88 MG/ML / phenylephrine 10.16 MG/ML [Omidria] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1540235 | OMIDRIA 1 % / 0.3 % Concentrate for Ophthalmic Irrigation Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1540235 | OMIDRIA 1 % / 0.3 % Concentrate for Ophthalmic Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1540235 | OMIDRIA 1 % / 0.3 % Concentrate for Ophthalmic Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1540235 | OMIDRIA 1 % / 0.3 % Concentrate for Ophthalmic Irrigation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1540238 | Brassica rapa subsp. rapa seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1540239 | Lavandula stoechas whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1540240 | Vaccinium angustifolium whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1540241 | clindamycin phosphate 1.2 % / benzoyl peroxide 5 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1540241 | clindamycin phosphate 1.2 % / benzoyl peroxide 5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1540241 | clindamycin phosphate 1.2 % / benzoyl peroxide 5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1540242 | Neuac | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1540243 | benzoyl peroxide 0.05 MG/MG / clindamycin phosphate 0.012 MG/MG [Neuac] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1540244 | benzoyl peroxide / clindamycin Topical Gel [Neuac] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1540245 | Neuac Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1540246 | Neuac 1.2 % / 5 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1540246 | Neuac 1.2 % / 5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1540246 | Neuac 1.2 % / 5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1540273 | PEG-10 glyceryl triisostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1540274 | Olay Fresh Effects Clear Skin Spot Zinger | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1540275 | salicylic acid 20 MG/ML [Olay Fresh Effects Clear Skin Spot Zinger] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1540276 | salicylic acid Topical Lotion [Olay Fresh Effects Clear Skin Spot Zinger] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1540277 | Olay Fresh Effects Clear Skin Spot Zinger Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1540278 | Olay fresh effects SPOT ZINGER 2 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1540278 | Olay fresh effects SPOT ZINGER 2 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1540278 | Olay fresh effects SPOT ZINGER 2 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1540278 | Olay fresh effects SPOT ZINGER 2 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1540332 | hydrocortisone Topical Cream [Proctosol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1540333 | Proctosol Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1540336 | Baclezene | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1540337 | neomycin 5 MG/ML [Baclezene] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1540338 | neomycin Topical Cream [Baclezene] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1540339 | Baclezene Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1540340 | Baclezene 5 MG/ML Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1540340 | Baclezene 5 MG/ML Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1540340 | Baclezene 5 MG/ML Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1540340 | Baclezene 5 MG/ML Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1540356 | Proctosol-HC 2.5 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1540356 | Proctosol-HC 2.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1540356 | Proctosol-HC 2.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1540356 | Proctosol-HC 2.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1540357 | peanut oil, hydrogenated | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1540358 | petrolatum 0.67 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1540359 | petrolatum 67 % / zinc oxide 13 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1540359 | petrolatum 67 % / zinc oxide 13 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1540359 | petrolatum 67 % / zinc oxide 13 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1540359 | petrolatum 67 % / zinc oxide 13 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1540360 | hypromellose 17 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1540361 | hypromellose 1.7 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1540361 | hypromellose 1.7 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1540361 | hypromellose 1.7 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1540452 | Powder for Nasal Solution | Dose Form (DF) | YES | |
| Concept ID (RxCUI): 1540453 | Granules for Oral Solution | Dose Form (DF) | YES | |
| Concept ID (RxCUI): 1540454 | Granules for Oral Suspension | Dose Form (DF) | YES | |
| Concept ID (RxCUI): 1540455 | Powder for Oral Solution | Dose Form (DF) | YES | |
| Concept ID (RxCUI): 1540456 | Powder for Oral Suspension | Dose Form (DF) | YES | |
| Concept ID (RxCUI): 1540496 | salicyloyl phytosphingosine Shampoo Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1540497 | salicyloyl phytosphingosine Medicated Shampoo | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1540498 | salicyloyl phytosphingosine 0.02 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1540498 | salicyloyl phytosphingosine 0.02 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1540498 | salicyloyl phytosphingosine 0.02 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1540499 | capsaicin 2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1540500 | capsaicin 0.2 % / menthol 12 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1540500 | capsaicin 0.2 % / menthol 12 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1540500 | capsaicin 0.2 % / menthol 12 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1540501 | Soothanol X2 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1540502 | capsaicin 2 MG/ML / menthol 120 MG/ML [Soothanol X2] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1540503 | capsaicin / menthol Topical Solution [Soothanol X2] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1540504 | Soothanol X2 Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1540505 | SOOTHANOL X2 0.2 % / 12 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1540505 | SOOTHANOL X2 0.2 % / 12 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1540505 | SOOTHANOL X2 0.2 % / 12 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1540507 | acetaminophen 80 MG / chlorpheniramine maleate 0.5 MG / phenylephrine HCl 1.25 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1540507 | acetaminophen 80 MG / chlorpheniramine maleate 0.5 MG / phenylephrine HCl 1.25 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1540507 | acetaminophen 80 MG / chlorpheniramine maleate 0.5 MG / phenylephrine HCl 1.25 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1540523 | ethylbenzene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1540524 | aluminum hydride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1540525 | aminoethylphosphinic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1540526 | edetate dipotassium anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1540658 | allantoin 0.02 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1540659 | allantoin / lidocaine / petrolatum Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1540662 | allantoin / lidocaine / petrolatum | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 1540663 | allantoin 2 % / lidocaine 4 % / petrolatum 30 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1540663 | allantoin 2 % / lidocaine 4 % / petrolatum 30 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1540663 | allantoin 2 % / lidocaine 4 % / petrolatum 30 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1540664 | Vexa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1540665 | allantoin 0.02 MG/MG / lidocaine 0.04 MG/MG / petrolatum 0.3 MG/MG [Vexa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1540667 | Vexa Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1540669 | Vexa-D 2 % / 4 % / 30 % Medicated Patch | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1540669 | Vexa-D 2 % / 4 % / 30 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1540669 | Vexa-D 2 % / 4 % / 30 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1540676 | menthol 11 % / methyl salicylate 11 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1540676 | menthol 11 % / methyl salicylate 11 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1540676 | menthol 11 % / methyl salicylate 11 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 154077 | Coronary vasodilator | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 154077 | Coronary vasodilator | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1540822 | Brucella abortus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1540823 | escargot shell, cooked | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1540824 | tedizolid phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1540824 | tedizolid phosphate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1540824 | tedizolid phosphate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1540825 | tedizolid | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1540825 | tedizolid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1540825 | tedizolid | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1540825 | tedizolid | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1540825 | tedizolid | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1540826 | behenyl erucate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1540827 | Cardiospermum halicacbum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1540828 | n-perfluorohexane | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1540828 | n-perfluorohexane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1540828 | n-perfluorohexane | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1540828 | n-perfluorohexane | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1540828 | n-perfluorohexane | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1540828 | n-perfluorohexane | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1540829 | Fortolin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1540830 | acetaminophen 500 MG [Fortolin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1540831 | acetaminophen Oral Tablet [Fortolin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1540832 | Fortolin Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1540833 | Fortolin Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1540834 | Fortolin 500 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1540834 | Fortolin 500 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1540834 | Fortolin 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1540834 | Fortolin 500 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1540835 | petrolatum 0.933 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1540836 | petrolatum Rectal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1540837 | petrolatum Rectal Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1540838 | petrolatum 93.3 % Rectal Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1540838 | petrolatum 93.3 % Rectal Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1540838 | petrolatum 93.3 % Rectal Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1540839 | Hemo-Fin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1540840 | petrolatum 0.933 MG/MG [Hemo-Fin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1540841 | petrolatum Rectal Ointment [Hemo-Fin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1540842 | Hemo-Fin Rectal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1540843 | Hemo-Fin 93.3 % Rectal Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1540843 | Hemo-Fin 93.3 % Rectal Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1540843 | Hemo-Fin 93.3 % Rectal Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1540844 | ferrous fumarate 456 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1540845 | iron (as ferrous fumarate) 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1540845 | iron (as ferrous fumarate) 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1540846 | ferrous fumarate 456 MG [Ferrimin 150] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1540847 | Ferrimin (iron) 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1540847 | Ferrimin (iron) 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1540847 | Ferrimin (iron) 150 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1540850 | Vetropolycin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1540851 | bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG [Vetropolycin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1540852 | bacitracin / neomycin / polymyxin B Ophthalmic Ointment [Vetropolycin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1540853 | Vetropolycin Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1540854 | VETROPOLYCIN 400 UNT / 3.5 MG / 10,000 UNT per GM Ophthalmic Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1540854 | VETROPOLYCIN 400 UNT / 3.5 MG / 10,000 UNT per GM Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1540854 | VETROPOLYCIN 400 UNT / 3.5 MG / 10,000 UNT per GM Ophthalmic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1540858 | tedizolid phosphate 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1540859 | tedizolid Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1540859 | tedizolid Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1540859 | tedizolid Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1540860 | tedizolid Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1540861 | tedizolid Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1540862 | tedizolid phosphate 200 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1540862 | tedizolid phosphate 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1540862 | tedizolid phosphate 200 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1540862 | tedizolid phosphate 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1540863 | Sivextro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1540864 | tedizolid phosphate 200 MG [Sivextro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1540865 | tedizolid Oral Tablet [Sivextro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1540866 | Sivextro Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1540867 | Sivextro Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1540868 | Sivextro 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1540868 | Sivextro 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1540868 | Sivextro 200 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1540869 | Jasminum sambac flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1540870 | ethyl methicone (8 MPA.S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1540871 | ethyl perfluorobutyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1540872 | Eucalyptus radiata flower top oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1540873 | meadowfoam seed oil fatty acids | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1540874 | Centipeda minima whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1540875 | perfluoroperhydrophenanthrene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1540876 | polyglyceryl-4-oleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1540877 | Chondrus crispus carrageenan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1540878 | octyldodecyl behenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1540879 | undecyl ethyleneglycol monoether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1540880 | Cistus ladanifer resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1540881 | hydrogenated jojoba oil, randomized | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1540882 | glycolide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1540884 | tedizolid Injectable Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1540884 | tedizolid Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1540884 | tedizolid Injectable Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1540886 | tedizolid phosphate 200 MG Injection | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1540886 | tedizolid phosphate 200 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1540886 | tedizolid phosphate 200 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1540886 | tedizolid phosphate 200 MG Injection | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1540889 | Sivextro Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1540890 | Sivextro 200 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1540890 | Sivextro 200 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1540890 | Sivextro 200 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1540973 | benzocaine 0.035 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1540974 | benzocaine 3.5 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1540974 | benzocaine 3.5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1540974 | benzocaine 3.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1540980 | Fluriso | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1540981 | isoflurane 999 MG/ML [Fluriso] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1540983 | Fluriso Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1540984 | Fluriso 99.9 % Inhalation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1540984 | Fluriso 99.9 % Inhalation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1540984 | Fluriso 99.9 % Inhalation Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1541083 | capsaicin 0.035 % / menthol 10 % / methyl salicylate 25 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1541083 | capsaicin 0.035 % / menthol 10 % / methyl salicylate 25 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1541083 | capsaicin 0.035 % / menthol 10 % / methyl salicylate 25 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1541084 | hydrocortisone 1 % / pramoxine HCl 1 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541084 | hydrocortisone 1 % / pramoxine HCl 1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541084 | hydrocortisone 1 % / pramoxine HCl 1 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1541086 | allantoin 0.5 % / dimethicone 5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541086 | allantoin 0.5 % / dimethicone 5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541086 | allantoin 0.5 % / dimethicone 5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1541087 | Anti Bac | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1541088 | benzoyl peroxide 50 MG/ML [Anti Bac] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1541089 | benzoyl peroxide Topical Lotion [Anti Bac] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1541090 | Anti Bac Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1541091 | Anti Bac 5 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541091 | Anti Bac 5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541091 | Anti Bac 5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541091 | Anti Bac 5 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1541092 | chloroxylenol 4.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1541093 | triclosan 0.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1541094 | chloroxylenol 0.45 % / triclosan 0.06 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541094 | chloroxylenol 0.45 % / triclosan 0.06 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541094 | chloroxylenol 0.45 % / triclosan 0.06 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1541095 | Clodan | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1541096 | clobetasol propionate 0.5 MG/ML [Clodan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1541097 | clobetasol Medicated Shampoo [Clodan] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1541098 | Clodan Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1541099 | Clodan 0.05 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1541099 | Clodan 0.05 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1541099 | Clodan 0.05 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1541099 | Clodan 0.05 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1541100 | Dermalquench Clear | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1541101 | salicylic acid 0.005 MG/MG [Dermalquench Clear] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1541102 | salicylic acid Topical Gel [Dermalquench Clear] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1541103 | Dermalquench Clear Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1541104 | DermalQuench Clear 0.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541104 | DermalQuench Clear 0.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541104 | DermalQuench Clear 0.5 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1541105 | Hydraclear | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1541106 | salicylic acid 0.005 MG/MG [Hydraclear] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1541107 | salicylic acid Topical Gel [Hydraclear] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1541108 | Hydraclear Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1541109 | HydraClear 0.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541109 | HydraClear 0.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541109 | HydraClear 0.5 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1541111 | Vetropolycin HC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1541112 | bacitracin 0.4 UNT/MG / hydrocortisone 0.01 MG/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG [Vetropolycin HC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1541113 | bacitracin / hydrocortisone / neomycin / polymyxin B Ophthalmic Ointment [Vetropolycin HC] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1541114 | Vetropolycin HC Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1541115 | VETROPOLYCIN HC 400 UNT / 10 MG / 3.5 MG / 10,000 UNT per GM Ophthalmic Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1541115 | VETROPOLYCIN HC 400 UNT / 10 MG / 3.5 MG / 10,000 UNT per GM Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541115 | VETROPOLYCIN HC 400 UNT / 10 MG / 3.5 MG / 10,000 UNT per GM Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541115 | VETROPOLYCIN HC 400 UNT / 10 MG / 3.5 MG / 10,000 UNT per GM Ophthalmic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541116 | caprylyl caprylate-caprate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 154114 | Substance with elastase inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 154114 | Substance with elastase inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 154114 | Substance with elastase inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 154114 | Substance with elastase inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 154114 | Substance with elastase inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1541209 | camphor 3.1 % / menthol 8 % / methyl salicylate 10 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1541209 | camphor 3.1 % / menthol 8 % / methyl salicylate 10 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541209 | camphor 3.1 % / menthol 8 % / methyl salicylate 10 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541210 | chlorhexidine / hydrocortisone Shampoo Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1541211 | chlorhexidine / hydrocortisone Medicated Shampoo | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1541212 | chlorhexidine / hydrocortisone | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1541213 | chlorhexidine gluconate 4 % / hydrocortisone 1 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541213 | chlorhexidine gluconate 4 % / hydrocortisone 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541213 | chlorhexidine gluconate 4 % / hydrocortisone 1 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1541215 | methotrexate 2.5 MG (12) (7.5 MG per Week) Oral Tablet Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| Concept ID (RxCUI): 1541215 | methotrexate 2.5 MG (12) (7.5 MG per Week) Oral Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541216 | Rheumatrex 2.5 MG (12) (7.5 MG per Week) Oral Tablet Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| Concept ID (RxCUI): 1541216 | Rheumatrex 2.5 MG (12) (7.5 MG per Week) Oral Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541216 | Rheumatrex 2.5 MG (12) (7.5 MG per Week) Oral Tablet Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541217 | methotrexate 2.5 MG (16) (10 MG per Week) Oral Tablet Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| Concept ID (RxCUI): 1541217 | methotrexate 2.5 MG (16) (10 MG per Week) Oral Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541218 | Rheumatrex 2.5 MG (16) (10 MG per Week) Oral Tablet Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| Concept ID (RxCUI): 1541218 | Rheumatrex 2.5 MG (16) (10 MG per Week) Oral Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541218 | Rheumatrex 2.5 MG (16) (10 MG per Week) Oral Tablet Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541220 | methotrexate 2.5 MG (20) (12.5 MG per Week) Oral Tablet Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| Concept ID (RxCUI): 1541220 | methotrexate 2.5 MG (20) (12.5 MG per Week) Oral Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541221 | Rheumatrex 2.5 MG (20) (12.5 MG per Week) Oral Tablet Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| Concept ID (RxCUI): 1541221 | Rheumatrex 2.5 MG (20) (12.5 MG per Week) Oral Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541221 | Rheumatrex 2.5 MG (20) (12.5 MG per Week) Oral Tablet Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541222 | methotrexate 2.5 MG (24) (15 MG per Week) Oral Tablet Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| Concept ID (RxCUI): 1541222 | methotrexate 2.5 MG (24) (15 MG per Week) Oral Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541224 | Rheumatrex 2.5 MG (24) (15 MG per Week) Oral Tablet Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| Concept ID (RxCUI): 1541224 | Rheumatrex 2.5 MG (24) (15 MG per Week) Oral Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541224 | Rheumatrex 2.5 MG (24) (15 MG per Week) Oral Tablet Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541225 | methotrexate 2.5 MG Oral Tablet (28) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| Concept ID (RxCUI): 1541225 | methotrexate 2.5 MG Oral Tablet (28) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541226 | Rheumatrex Dose Pack 28, 4 Week Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| Concept ID (RxCUI): 1541226 | Rheumatrex Dose Pack 28, 4 Week Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541226 | Rheumatrex Dose Pack 28, 4 Week Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541227 | methotrexate 2.5 MG Oral Tablet (32) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| Concept ID (RxCUI): 1541227 | methotrexate 2.5 MG Oral Tablet (32) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541228 | Rheumatrex Dose Pack 32, 4 Week Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| Concept ID (RxCUI): 1541228 | Rheumatrex Dose Pack 32, 4 Week Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541228 | Rheumatrex Dose Pack 32, 4 Week Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541229 | zinc oxide 5 % / dimethicone 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541229 | zinc oxide 5 % / dimethicone 1 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1541229 | zinc oxide 5 % / dimethicone 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541229 | zinc oxide 5 % / dimethicone 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541233 | Achromycin V 500 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541233 | Achromycin V 500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541233 | Achromycin V 500 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1541234 | ammonium acryloyldimethyltaurate - beheneth-25 methacrylate crosspolymer (52000 MPA.S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541235 | biosaccharide gum-2 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541236 | C12-17 alkane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541237 | Eupolyphaga sinensis preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541238 | ferrous cation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1541239 | Fragaria vesca whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 154124 | Ether hydrolase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 154124 | Ether hydrolase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1541240 | Geum urbanum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541241 | Petasites hybridus root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541242 | Quercus robur whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541243 | Rheum tanguticum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541244 | Sphagnum squarrosum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1541245 | dipotassium glucose-6-phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1541246 | Glucose-6-phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1541246 | Glucose-6-phosphate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1541246 | Glucose-6-phosphate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1541247 | ethyl perfluoroisobutyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1541248 | PEG-PPG-25-25 dimethicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541249 | polignate sodium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541250 | Acnefree BP | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1541251 | benzoyl peroxide 100 MG/ML [Acnefree BP] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1541252 | benzoyl peroxide Topical Lotion [Acnefree BP] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1541253 | Acnefree BP Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1541254 | AcneFree BP 10 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541254 | AcneFree BP 10 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541254 | AcneFree BP 10 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1541259 | benzoyl peroxide 3.7 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541259 | benzoyl peroxide 3.7 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541259 | benzoyl peroxide 3.7 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1541260 | benzoyl peroxide 37 MG/ML [Acnefree BP] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1541261 | AcneFree BP 3.7 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541261 | AcneFree BP 3.7 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541261 | AcneFree BP 3.7 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1541263 | Acnefree SA | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1541264 | salicylic acid 20 MG/ML [Acnefree SA] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1541265 | salicylic acid Medicated Pad [Acnefree SA] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1541266 | Acnefree SA Medicated Pad or Tape | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1541267 | Acnefree SA Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1541268 | Acnefree SA 2 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541268 | Acnefree SA 2 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541268 | Acnefree SA 2 % Medicated Pad | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 154134 | Flavonoid | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 154134 | Flavonoid | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 154134 | Flavonoid | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 154134 | Flavonoid | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1541465 | dalbavancin hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1541465 | dalbavancin hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1541465 | dalbavancin hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1541591 | menthol 0.08 MG/MG [Stopain] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1541592 | Stopain COLD 8 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1541592 | Stopain COLD 8 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541592 | Stopain COLD 8 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541592 | Stopain COLD 8 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541593 | potassium chloride 8 MEQ [K-Tab] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1541594 | K-Tab 8 MEQ Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1541594 | K-Tab 8 MEQ Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1541594 | K-Tab 8 MEQ Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1541594 | K-Tab 8 MEQ Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1541594 | K-Tab 8 MEQ Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1541597 | polyvinyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1541608 | menthol 6 % / methyl salicylate 10 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1541608 | menthol 6 % / methyl salicylate 10 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541608 | menthol 6 % / methyl salicylate 10 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541609 | Dexedrine 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1541609 | Dexedrine 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1541609 | Dexedrine 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1541610 | salicylic acid 1 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1541610 | salicylic acid 1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541610 | salicylic acid 1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541617 | influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541618 | influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1541619 | influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1541620 | influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1541621 | influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1541622 | influenza virus vaccine 2014-2015 quadrivalent 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1541622 | influenza virus vaccine 2014-2015 quadrivalent 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541623 | Fluarix Quad 2014-2015 Formula | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1541624 | influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Fluarix Quad 2014-2015 Formula] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1541625 | influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Fluarix Quad 2014-2015 Formula] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1541626 | Fluarix Quad 2014-2015 Formula Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1541627 | 0.5 ML influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluarix Quad 2014-2015 Formula] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1541627 | 0.5 ML influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluarix Quad 2014-2015 Formula] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541628 | influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1541629 | influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluarix Quad 2014-2015 Formula] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1541630 | codeine phosphate 10 MG / brompheniramine maleate 4 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1541630 | codeine phosphate 10 MG / brompheniramine maleate 4 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1541630 | codeine phosphate 10 MG / brompheniramine maleate 4 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1541636 | colloidal oatmeal 0.7 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1541641 | camphor 6 % / menthol 1.25 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541641 | camphor 6 % / menthol 1.25 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541641 | camphor 6 % / menthol 1.25 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1541696 | salicylic acid 2 % Topical Gel (30 ML) / salicylic acid 2 % Medicated Liquid Soap (150 ML) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| Concept ID (RxCUI): 1541696 | salicylic acid 2 % Topical Gel (30 ML) / salicylic acid 2 % Medicated Liquid Soap (150 ML) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541697 | Take Control | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1541698 | salicylic acid 20 MG/ML [Take Control] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1541699 | salicylic acid Medicated Liquid Soap [Take Control] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1541700 | Take Control Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1541701 | Take Control 2 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1541701 | Take Control 2 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541701 | Take Control 2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541702 | Let Me Clarify | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1541703 | salicylic acid 0.02 MG/MG [Let Me Clarify] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1541704 | salicylic acid Topical Gel [Let Me Clarify] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1541705 | Let Me Clarify Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1541706 | Let Me Clarify 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541706 | Let Me Clarify 2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541706 | Let Me Clarify 2 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1541707 | Erase It Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| Concept ID (RxCUI): 1541707 | Erase It Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541707 | Erase It Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541708 | Arctium lappa fruit oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541709 | Mallotus japonicus flower oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541710 | Rubus idaeus fruit volatile oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1541711 | Santalum album seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541712 | Zingiber cassumunar root oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541714 | Cimicifuga simplex root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541715 | Citrus aurantiifolia whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541716 | Coriandrum sativum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1541717 | Cucurbita pepo whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1541718 | Eremocitrus glauca fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1541719 | Jasminum officinale whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1541720 | Laurus nobilis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541721 | Sesamum indicum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541722 | Lawsonia inermis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541723 | Pinus densiflora leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1541724 | Triticum polonicum seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541725 | Gardenia resinifera resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541726 | Cananga odorata flower wax | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541727 | Brassica oleracea var. italica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1541728 | Eruca vesicaria subsp. sativa leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541729 | mammal bone, fossilized | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1541730 | Cinnamomum camphora resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541731 | Eucalyptus gum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1541732 | Coix lacryma-jobi var. ma-yuen seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541733 | hydroxyacetophenone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1541733 | hydroxyacetophenone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1541734 | biosaccharide gum-4 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1541735 | black catechu extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541736 | quaternium-82 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541737 | capramidopropyl betaine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541738 | steareth-20 methacrylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541739 | steareth-7 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541740 | Taraxacum mongolicum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541740 | Taraxacum mongolicum whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541741 | hydroxypropyl bisstearamide monoethanolamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541742 | sodium hinokitiol | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1541743 | trehalose isostearate esters | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541744 | cholesteryl isostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541745 | dipentaerythrityl hexastearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541746 | methyl ricinoleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541747 | polyglyceryl-10 hexaoleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541749 | polyglycerol polyricinoleic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1541750 | glyceran polyricinoleic acid ester | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541811 | Bencocaine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1541812 | benzocaine 0.2 MG/MG [Bencocaine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1541813 | benzocaine Oral Gel [Bencocaine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1541814 | Bencocaine Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1541815 | Bencocaine Oral Gel Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1541816 | BencoCaine 20 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1541816 | BencoCaine 20 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541816 | BencoCaine 20 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1541816 | BencoCaine 20 % Oral Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1541881 | Angelica gigas root oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541882 | Artemisia vulgaris whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1541883 | Cnidium officinale root oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541884 | Gardenia jasminoides whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1541885 | PPG-26 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541886 | PEG-8 propylheptyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1541889 | sunitinib 37.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1541889 | sunitinib 37.5 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1541890 | SUNItinib malate 37.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1541890 | SUNItinib malate 37.5 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1541890 | SUNItinib malate 37.5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1541890 | SUNItinib malate 37.5 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1541890 | SUNItinib malate 37.5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1541927 | sunitinib 37.5 MG [Sutent] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1541927 | sunitinib 37.5 MG [Sutent] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1541928 | Sutent 37.5 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1541928 | Sutent 37.5 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1541928 | Sutent 37.5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1541928 | Sutent 37.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1541929 | Liquimat | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1541930 | sulfur 50 MG/ML [Liquimat] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1541931 | sulfur Topical Lotion [Liquimat] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1541932 | Liquimat Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1541933 | Liquimat 5 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1541933 | Liquimat 5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1541933 | Liquimat 5 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1542375 | pentaerythrityl tetrabehenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1542377 | sulfacetamide sodium 9.8 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1542377 | sulfacetamide sodium 9.8 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1542378 | sulfacetamide sodium 98 MG/ML [Ovace] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1542379 | sulfacetamide Topical Lotion [Ovace] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1542380 | Ovace Plus 9.8 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1542380 | Ovace Plus 9.8 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1542380 | Ovace Plus 9.8 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1542380 | Ovace Plus 9.8 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1542381 | Vazculep | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1542382 | phenylephrine hydrochloride 10 MG/ML [Vazculep] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1542383 | phenylephrine Injectable Solution [Vazculep] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1542384 | Vazculep Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1542385 | Vazculep 10 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1542385 | Vazculep 10 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1542385 | Vazculep 10 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1542385 | Vazculep 10 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1542385 | Vazculep 10 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1542386 | buprenorphine 2.1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1542387 | naloxone 0.3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1542388 | buprenorphine / naloxone Buccal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1542389 | buprenorphine / naloxone Buccal Film | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1542390 | buprenorphine 2.1 MG / naloxone 0.3 MG Buccal Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1542390 | buprenorphine 2.1 MG / naloxone 0.3 MG Buccal Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1542391 | Bunavail | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1542392 | buprenorphine 2.1 MG / naloxone 0.3 MG [Bunavail] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1542393 | buprenorphine / naloxone Buccal Film [Bunavail] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1542394 | Bunavail Buccal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1542395 | Bunavail Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1542396 | Bunavail 2.1 / 0.3 Buccal Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1542396 | Bunavail 2.1 / 0.3 Buccal Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1542396 | Bunavail 2.1 / 0.3 Buccal Film | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1542397 | (APAP 500 MG / dextromethorphan HBr 20 MG / doxylamine succinate 12.5 MG / phenylephrine HCl 10 MG) per 240 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1542397 | (APAP 500 MG / dextromethorphan HBr 20 MG / doxylamine succinate 12.5 MG / phenylephrine HCl 10 MG) per 240 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1542397 | (APAP 500 MG / dextromethorphan HBr 20 MG / doxylamine succinate 12.5 MG / phenylephrine HCl 10 MG) per 240 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1542452 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1542452 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 10 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1542452 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 10 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1542452 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1542452 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 10 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1542452 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 10 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1542452 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 10 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1542454 | calcium chlorate dihydrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1542518 | buprenorphine 6.3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1542796 | hydrocortisone acetate 2 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1542796 | hydrocortisone acetate 2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1542797 | hydrocortisone acetate 0.02 MG/MG [CortAlo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1542798 | CortAlo 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1542798 | CortAlo 2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1542798 | CortAlo 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1542798 | CortAlo 2 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1542800 | benzocaine Oral Gel [Zilactin B] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1542801 | Zilactin B Oral Gel Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1542802 | Zilactin B Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1542803 | zilactin-B 10 % Oral Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1542803 | zilactin-B 10 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1542803 | zilactin-B 10 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1542803 | zilactin-B 10 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1542804 | hydrocortisone acetate 0.5 % / neomycin 0.35 % / polymyxin B 10,000 UNT/ML Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1542804 | hydrocortisone acetate 0.5 % / neomycin 0.35 % / polymyxin B 10,000 UNT/ML Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1542804 | hydrocortisone acetate 0.5 % / neomycin 0.35 % / polymyxin B 10,000 UNT/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1542805 | hydrocortisone acetate 5 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML [Cortisporin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1542806 | CORTISPORIN 0.5 % / 0.35 % / 10,000 UNT per GM Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1542806 | CORTISPORIN 0.5 % / 0.35 % / 10,000 UNT per GM Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1542806 | CORTISPORIN 0.5 % / 0.35 % / 10,000 UNT per GM Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1542806 | CORTISPORIN 0.5 % / 0.35 % / 10,000 UNT per GM Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1542812 | tetracycline hydrochloride 0.03 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1542813 | tetracycline HCl 3 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1542813 | tetracycline HCl 3 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1542813 | tetracycline HCl 3 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1542814 | tetracycline hydrochloride 0.03 MG/MG [Diabecline] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1542815 | Diabecline 3 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1542815 | Diabecline 3 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1542815 | Diabecline 3 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1542815 | Diabecline 3 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1542816 | camphor 11 % / menthol 7.6 % / methyl salicylate 13 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1542816 | camphor 11 % / menthol 7.6 % / methyl salicylate 13 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1542817 | camphor 0.11 MG/MG / menthol 0.076 MG/MG / methyl salicylate 0.13 MG/MG [Katinko] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1542818 | Katinko (camphor 11 % / menthol 7.6 % / methyl salicylate 13 % ) Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1542818 | Katinko (camphor 11 % / menthol 7.6 % / methyl salicylate 13 % ) Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1542818 | Katinko (camphor 11 % / menthol 7.6 % / methyl salicylate 13 % ) Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1542819 | histamine dihydrochloride 0.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1542820 | histamine dihydrochloride 0.05 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1542820 | histamine dihydrochloride 0.05 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1542820 | histamine dihydrochloride 0.05 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1542821 | Australian Dream | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1542822 | histamine dihydrochloride 0.5 MG/ML [Australian Dream] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1542823 | histamine Topical Cream [Australian Dream] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1542824 | Australian Dream Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1542825 | Australian Dream 0.05 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1542825 | Australian Dream 0.05 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1542825 | Australian Dream 0.05 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1542834 | tetracycline hydrochloride 0.03 MG/MG [Achromycin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1542835 | Achromycin 3 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1542835 | Achromycin 3 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1542835 | Achromycin 3 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1542857 | salicylic acid Medicated Liquid Soap [No Zit Sherlock] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1542858 | No Zit Sherlock Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1542859 | no 'zit' sherlock purifying 2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1542859 | no 'zit' sherlock purifying 2 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1542859 | no 'zit' sherlock purifying 2 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1542893 | Olioactiv | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1542894 | cetylpyridinium chloride 0.5 MG/ML [Olioactiv] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1542895 | cetylpyridinium Mouthwash [Olioactiv] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1542896 | Olioactiv Dental Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1542897 | Olioactiv Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1542898 | Olioactiv Mouthwash Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1542899 | olio activ 0.05 % Mouthwash | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1542899 | olio activ 0.05 % Mouthwash | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1542899 | olio activ 0.05 % Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1542900 | cauloside D | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1542901 | propylene glycol 1-(2-methylbutyrate) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1542917 | sodium chloride 2300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1542918 | sodium bicarbonate / sodium chloride Powder for Nasal Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1542919 | sodium bicarbonate 700 MG / sodium chloride 2300 MG Powder for Nasal Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1542919 | sodium bicarbonate 700 MG / sodium chloride 2300 MG Powder for Nasal Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1542919 | sodium bicarbonate 700 MG / sodium chloride 2300 MG Powder for Nasal Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1542920 | hydrocortisone acetate 0.5 % Ophthalmic Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1542920 | hydrocortisone acetate 0.5 % Ophthalmic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1542920 | hydrocortisone acetate 0.5 % Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1542920 | hydrocortisone acetate 0.5 % Ophthalmic Ointment | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1542920 | hydrocortisone acetate 0.5 % Ophthalmic Ointment | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1542921 | hydrocortisone acetate 1 % Ophthalmic Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1542921 | hydrocortisone acetate 1 % Ophthalmic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1542921 | hydrocortisone acetate 1 % Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1542921 | hydrocortisone acetate 1 % Ophthalmic Ointment | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1542921 | hydrocortisone acetate 1 % Ophthalmic Ointment | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1542922 | hydrocortisone acetate 2.5 % Ophthalmic Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1542922 | hydrocortisone acetate 2.5 % Ophthalmic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1542922 | hydrocortisone acetate 2.5 % Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1542922 | hydrocortisone acetate 2.5 % Ophthalmic Ointment | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1542922 | hydrocortisone acetate 2.5 % Ophthalmic Ointment | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1542924 | hydrocortisone acetate 0.015 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1542925 | hydrocortisone acetate 1.5 % Ophthalmic Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1542925 | hydrocortisone acetate 1.5 % Ophthalmic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1542925 | hydrocortisone acetate 1.5 % Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1542927 | miconazole Vaginal Ointment [Femmesil] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1542928 | Femmesil Vaginal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1542929 | Femmesil 2 % Vaginal Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1542929 | Femmesil 2 % Vaginal Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1542929 | Femmesil 2 % Vaginal Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1542941 | vancomycin (as vancomycin hydrochloride) 25 MG/ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1542941 | vancomycin (as vancomycin hydrochloride) 25 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1542942 | vancomycin (as vancomycin hydrochloride) 50 MG/ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1542942 | vancomycin (as vancomycin hydrochloride) 50 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1542976 | Verdrocet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1542977 | acetaminophen 325 MG / hydrocodone bitartrate 2.5 MG [Verdrocet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1542977 | acetaminophen 325 MG / hydrocodone bitartrate 2.5 MG [Verdrocet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1542978 | acetaminophen / hydrocodone Oral Tablet [Verdrocet] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1542978 | acetaminophen / hydrocodone Oral Tablet [Verdrocet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1542979 | Verdrocet Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 154298 | Oxidoreductase inhibitor | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 154298 | Oxidoreductase inhibitor | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1542980 | Verdrocet Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1542981 | Verdrocet 2.5 MG / 325 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1542981 | Verdrocet 2.5 MG / 325 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1542981 | Verdrocet 2.5 MG / 325 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1542981 | Verdrocet 2.5 MG / 325 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1542981 | Verdrocet 2.5 MG / 325 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1542983 | Xylon | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1542984 | hydrocodone bitartrate 10 MG / ibuprofen 200 MG [Xylon] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1542984 | hydrocodone bitartrate 10 MG / ibuprofen 200 MG [Xylon] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1542985 | hydrocodone / ibuprofen Oral Tablet [Xylon] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1542985 | hydrocodone / ibuprofen Oral Tablet [Xylon] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1542986 | Xylon Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1542987 | Xylon Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1542988 | Xylon 10, 10 MG / 200 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1542988 | Xylon 10, 10 MG / 200 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1542988 | Xylon 10, 10 MG / 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1542988 | Xylon 10, 10 MG / 200 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1542988 | Xylon 10, 10 MG / 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1542990 | Neo-Synalar | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1542991 | fluocinolone acetonide 0.25 MG/ML / neomycin sulfate 5 MG/ML [Neo-Synalar] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1542992 | fluocinolone / neomycin Topical Cream [Neo-Synalar] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1542993 | Neo-Synalar Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1542994 | NEO-SYNALAR 0.5 % (0.35 % ) / 0.025 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1542994 | NEO-SYNALAR 0.5 % (0.35 % ) / 0.025 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1542994 | NEO-SYNALAR 0.5 % (0.35 % ) / 0.025 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1542995 | lidocaine 0.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1542995 | lidocaine 0.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1542995 | lidocaine 0.5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1542996 | buprenorphine 0.0075 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1542997 | buprenorphine 7.5 MCG/HR 7 Day Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1542997 | buprenorphine 7.5 MCG/HR 7 Day Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1542997 | buprenorphine 7.5 MCG/HR 7 Day Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1542997 | buprenorphine 7.5 MCG/HR 7 Day Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1542998 | buprenorphine 0.0075 MG/HR [BuTrans] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1542999 | Butrans 7.5 MCG/HR 7 Day Transdermal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1542999 | Butrans 7.5 MCG/HR 7 Day Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1542999 | Butrans 7.5 MCG/HR 7 Day Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1542999 | Butrans 7.5 MCG/HR 7 Day Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1542999 | Butrans 7.5 MCG/HR 7 Day Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543000 | buprenorphine 0.0075 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1543001 | buprenorphine 0.0075 MG/HR Transdermal System [BuTrans] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1543001 | buprenorphine 0.0075 MG/HR Transdermal System [BuTrans] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543001 | buprenorphine 0.0075 MG/HR Transdermal System [BuTrans] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543002 | amylase 15125 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1543003 | protease 14375 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1543004 | lipase 4000 UNT / amylase 15,125 UNT / protease 14,375 UNT Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543004 | lipase 4000 UNT / amylase 15,125 UNT / protease 14,375 UNT Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1543004 | lipase 4000 UNT / amylase 15,125 UNT / protease 14,375 UNT Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543004 | lipase 4000 UNT / amylase 15,125 UNT / protease 14,375 UNT Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1543005 | amylase 15125 UNT / lipase 4000 UNT / protease 14375 UNT [Pertzye] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1543006 | Pertzye 4000 UNT / 15,125 UNT / 14,375 UNT Delayed Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1543006 | Pertzye 4000 UNT / 15,125 UNT / 14,375 UNT Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543006 | Pertzye 4000 UNT / 15,125 UNT / 14,375 UNT Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543006 | Pertzye 4000 UNT / 15,125 UNT / 14,375 UNT Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1543069 | lidocaine 5 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1543069 | lidocaine 5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1543069 | lidocaine 5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543070 | acetaminophen / caffeine Oral Powder Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1543071 | acetaminophen / caffeine Oral Powder | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1543072 | acetaminophen 650 MG / caffeine 50 MG Oral Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1543072 | acetaminophen 650 MG / caffeine 50 MG Oral Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1543072 | acetaminophen 650 MG / caffeine 50 MG Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543073 | tripelennamine hydrochloride 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1543074 | tripelennamine HCl 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1543074 | tripelennamine HCl 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543074 | tripelennamine HCl 2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1543077 | Euphorbia hirta flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1543078 | methyl undecylenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1543079 | ethyl 10-undecenoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1543081 | certeareth-100 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1543082 | bergamot orange extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1543089 | Eloctate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1543092 | Eloctate Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1543095 | (1-743)-(1638-2332)-blood-coagulation factor VIII (synthetic human) fusion protein with immunoglobulin G1 (synthetic human fc domain fragment), (1444-6'),(1447-9')-bis(disulfide) with immunoglobulin G1 (synthetic human fc domain fragment) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543095 | (1-743)-(1638-2332)-blood-coagulation factor VIII (synthetic human) fusion protein with immunoglobulin G1 (synthetic human fc domain fragment), (1444-6'),(1447-9')-bis(disulfide) with immunoglobulin G1 (synthetic human fc domain fragment) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1543095 | (1-743)-(1638-2332)-blood-coagulation factor VIII (synthetic human) fusion protein with immunoglobulin G1 (synthetic human fc domain fragment), (1444-6'),(1447-9')-bis(disulfide) with immunoglobulin G1 (synthetic human fc domain fragment) | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1543095 | (1-743)-(1638-2332)-blood-coagulation factor VIII (synthetic human) fusion protein with immunoglobulin G1 (synthetic human fc domain fragment), (1444-6'),(1447-9')-bis(disulfide) with immunoglobulin G1 (synthetic human fc domain fragment) | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1543095 | (1-743)-(1638-2332)-blood-coagulation factor VIII (synthetic human) fusion protein with immunoglobulin G1 (synthetic human fc domain fragment), (1444-6'),(1447-9')-bis(disulfide) with immunoglobulin G1 (synthetic human fc domain fragment) | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1543095 | (1-743)-(1638-2332)-blood-coagulation factor VIII (synthetic human) fusion protein with immunoglobulin G1 (synthetic human fc domain fragment), (1444-6'),(1447-9')-bis(disulfide) with immunoglobulin G1 (synthetic human fc domain fragment) | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1543097 | efmoroctocog alfa Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1543097 | efmoroctocog alfa Injectable Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1543097 | efmoroctocog alfa Injectable Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 154313 | Peptide hormone | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 154313 | Peptide hormone | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1543157 | tetracaine hydrochloride 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1543158 | tetracaine HCl 2 % Topical Cream | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1543158 | tetracaine HCl 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1543158 | tetracaine HCl 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543158 | tetracaine HCl 2 % Topical Cream | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1543158 | tetracaine HCl 2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1543159 | tetracaine hydrochloride 20 MG/ML [Viractin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1543160 | Viractin 2 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1543160 | Viractin 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1543160 | Viractin 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543160 | Viractin 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543161 | tetracaine hydrochloride 0.02 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1543162 | tetracaine HCl 2 % Topical Gel | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1543162 | tetracaine HCl 2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1543162 | tetracaine HCl 2 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1543162 | tetracaine HCl 2 % Topical Gel | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1543163 | tetracaine hydrochloride 0.02 MG/MG [Viractin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1543164 | Viractin 2 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1543164 | Viractin 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543164 | Viractin 2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1543165 | carbamide peroxide Oral Gel Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1543166 | carbamide peroxide Oral Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1543167 | carbamide peroxide 11 % Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1543167 | carbamide peroxide 11 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1543167 | carbamide peroxide 11 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543168 | Broda Acne Spa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1543169 | salicylic acid 0.02 MG/MG [Broda Acne Spa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1543170 | salicylic acid Topical Gel [Broda Acne Spa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1543171 | Broda Acne Spa Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1543172 | Broda Acne Spa 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543172 | Broda Acne Spa 2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1543172 | Broda Acne Spa 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543172 | Broda Acne Spa 2 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1543173 | tavaborole | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1543173 | tavaborole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1543173 | tavaborole | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1543173 | tavaborole | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1543173 | tavaborole | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1543174 | tavaborole 43.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1543175 | tavaborole Topical Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1543175 | tavaborole Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1543175 | tavaborole Topical Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1543176 | tavaborole Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1543177 | tavaborole 5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1543177 | tavaborole 5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1543177 | tavaborole 5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543178 | Kerydin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1543179 | tavaborole 43.5 MG/ML [Kerydin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1543180 | tavaborole Topical Solution [Kerydin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1543181 | Kerydin Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1543182 | KERYDIN 5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543182 | KERYDIN 5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1543182 | KERYDIN 5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543182 | KERYDIN 5 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1543185 | sucrose octastearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1543187 | testosterone 5.5 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1543188 | testosterone Nasal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1543189 | testosterone Nasal Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1543190 | testosterone 5.5 MG/ACTUAT Nasal Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1543191 | Natesto | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1543192 | testosterone 5.5 MG/ACTUAT [Natesto] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1543193 | testosterone Nasal Gel [Natesto] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1543194 | Natesto Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1543195 | testosterone 5.5 MG/ACTUAT Nasal Gel [Natesto] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543195 | testosterone 5.5 MG/ACTUAT Nasal Gel [Natesto] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1543196 | camphor 11 % / menthol 7.6 % / methyl salicylate 13.5 % Topical Stick | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1543196 | camphor 11 % / menthol 7.6 % / methyl salicylate 13.5 % Topical Stick | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1543196 | camphor 11 % / menthol 7.6 % / methyl salicylate 13.5 % Topical Stick | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543197 | camphor 0.11 MG/MG / menthol 0.076 MG/MG / methyl salicylate 0.135 MG/MG [Katinko] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1543198 | Katinko 11 % / 7.6 % / 13.5 % Topical Stick | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1543198 | Katinko 11 % / 7.6 % / 13.5 % Topical Stick | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543198 | Katinko 11 % / 7.6 % / 13.5 % Topical Stick | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1543200 | insulin, regular, human Inhalant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1543202 | regular insulin, human 4 UNT Inhalation Powder Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1543202 | regular insulin, human 4 UNT Inhalation Powder Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1543202 | regular insulin, human 4 UNT Inhalation Powder Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543203 | Afrezza | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1543206 | Afrezza Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1543207 | afrezza 4 UNT Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1543207 | afrezza 4 UNT Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543207 | afrezza 4 UNT Inhalation Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1543208 | testosterone 10 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1543209 | testosterone 10 MG/ACTUAT Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1543210 | testosterone 10 MG/ACTUAT [Fortesta] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1543211 | testosterone 10 MG/ACTUAT Topical Gel [Fortesta] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543211 | testosterone 10 MG/ACTUAT Topical Gel [Fortesta] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1543217 | testosterone 20.25 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1543218 | testosterone 20.25 MG/ACTUAT Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1543219 | testosterone 20.25 MG/ACTUAT [Androgel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1543220 | testosterone 20.25 MG/ACTUAT Topical Gel [Androgel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543220 | testosterone 20.25 MG/ACTUAT Topical Gel [Androgel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 154325 | Phenylalkylamine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 154325 | Phenylalkylamine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1543293 | Asplenium scolopendrium whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1543294 | Rosa x damascena whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1543294 | Rosa x damascena whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543308 | sulfacetamide sodium 9.8 % / sulfur 4.8 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1543308 | sulfacetamide sodium 9.8 % / sulfur 4.8 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543308 | sulfacetamide sodium 9.8 % / sulfur 4.8 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1543309 | Alevazol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1543310 | clotrimazole 0.01 MG/MG [Alevazol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1543311 | clotrimazole Topical Ointment [Alevazol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1543312 | Alevazol Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1543313 | Alevazol 1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543313 | Alevazol 1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1543313 | Alevazol 1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543313 | Alevazol 1 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1543390 | benzoyl peroxide 4.4 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1543390 | benzoyl peroxide 4.4 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543390 | benzoyl peroxide 4.4 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1543391 | benzoyl peroxide 44 MG/ML [Benoxyl] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1543392 | benzoyl peroxide Medicated Liquid Soap [Benoxyl] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1543393 | Benoxyl Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1543394 | Benoxyl-CR 4.4 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543394 | Benoxyl-CR 4.4 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1543394 | Benoxyl-CR 4.4 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1543398 | Xylamed | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1543399 | xylazine 100 MG/ML [Xylamed] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1543400 | xylazine Injectable Solution [Xylamed] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1543401 | Xylamed Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1543402 | xylazine 100 MG/ML Injectable Solution [Xylamed] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543402 | xylazine 100 MG/ML Injectable Solution [Xylamed] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543402 | xylazine 100 MG/ML Injectable Solution [Xylamed] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1543403 | Fluarix 2014-2015 Formula | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1543404 | influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Fluarix 2014-2015 Formula] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1543405 | influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Fluarix 2014-2015 Formula] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1543406 | Fluarix 2014-2015 Formula Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1543407 | 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluarix 2014-2015 Formula] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1543407 | 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluarix 2014-2015 Formula] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543408 | influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluarix 2014-2015 Formula] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1543411 | Fritillaria delavayi bulb extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1543414 | dihydroxyaluminum aminoacetate anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1543415 | PEG-11 avocado glycerides | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1543422 | neomycin 0.35 % / fluocinolone acetonide 0.025 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543422 | neomycin 0.35 % / fluocinolone acetonide 0.025 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1543422 | neomycin 0.35 % / fluocinolone acetonide 0.025 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1543429 | benzalkonium / benzocaine / menthol Oral Gel Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1543430 | benzalkonium / benzocaine / menthol Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1543431 | benzalkonium / benzocaine / menthol Oral Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1543432 | benzocaine 20 % / menthol 0.5 % / benzalkonium chloride 0.1 % Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1543432 | benzocaine 20 % / menthol 0.5 % / benzalkonium chloride 0.1 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1543432 | benzocaine 20 % / menthol 0.5 % / benzalkonium chloride 0.1 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543455 | methoxy PEG PPG-7-3 aminopropyl dimethicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1543458 | ketorolac / phenylephrine Ophthalmic Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1543459 | ketorolac / phenylephrine Ophthalmic Irrigation Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1543461 | ketorolac / phenylephrine Ophthalmic Irrigation Solution [Omidria] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1543462 | Omidria Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1543543 | belinostat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1543543 | belinostat | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1543543 | belinostat | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1543543 | belinostat | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1543543 | belinostat | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1543545 | belinostat Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1543545 | belinostat Injectable Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1543545 | belinostat Injectable Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1543547 | belinostat 500 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1543547 | belinostat 500 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1543547 | belinostat 500 MG Injection | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1543547 | belinostat 500 MG Injection | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1543548 | Beleodaq | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1543551 | Beleodaq Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1543552 | Beleodaq 500 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1543552 | Beleodaq 500 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543552 | Beleodaq 500 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1543553 | Nikki 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 1543553 | Nikki 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1543553 | Nikki 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543562 | Amlodipine mesilate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543562 | Amlodipine mesilate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1543562 | Amlodipine mesilate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1543563 | Fungus MD | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1543564 | tolnaftate 10 MG/ML [Fungus MD] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1543565 | tolnaftate Topical Solution [Fungus MD] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1543566 | Fungus MD Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1543567 | Fungus MD 1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1543567 | Fungus MD 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543567 | Fungus MD 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543567 | Fungus MD 1 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 154363 | Product containing pyrethroid (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 154363 | Product containing pyrethroid (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 154363 | Product containing pyrethroid (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 154363 | Product containing pyrethroid (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1543704 | dimethicone 1.1 % / zinc oxide 40 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1543704 | dimethicone 1.1 % / zinc oxide 40 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543704 | dimethicone 1.1 % / zinc oxide 40 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1543704 | dimethicone 1.1 % / zinc oxide 40 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543705 | Vanicream Diaper Rash | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1543706 | dimethicone 0.011 MG/MG / zinc oxide 0.4 MG/MG [Vanicream Diaper Rash] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1543707 | dimethicone / zinc oxide Topical Ointment [Vanicream Diaper Rash] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1543708 | Vanicream Diaper Rash Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1543709 | Vanicream Diaper Rash 1.1 % / 40 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1543709 | Vanicream Diaper Rash 1.1 % / 40 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543709 | Vanicream Diaper Rash 1.1 % / 40 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543709 | Vanicream Diaper Rash 1.1 % / 40 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1543710 | mineral oil 0.2 MG/MG / petrolatum 0.8 MG/MG [Tears Again Ointment] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1543711 | Tears Again Ointment 20 % / 80 % Ophthalmic Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1543711 | Tears Again Ointment 20 % / 80 % Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543711 | Tears Again Ointment 20 % / 80 % Ophthalmic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1543712 | lidocaine HCl 1 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1543712 | lidocaine HCl 1 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543712 | lidocaine HCl 1 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1543713 | RadiaGuard | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1543714 | lidocaine hydrochloride 10 MG/ML [RadiaGuard] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1543715 | lidocaine Topical Lotion [RadiaGuard] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1543716 | RadiaGuard Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1543717 | RadiaGuard 1 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1543717 | RadiaGuard 1 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1543717 | RadiaGuard 1 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543717 | RadiaGuard 1 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543722 | amylase 450 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1543724 | lipase 30 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1543725 | amylase / Bacillus coagulans / lipase / protease Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1543726 | amylase / Bacillus coagulans / lipase / protease Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1543727 | amylase / Bacillus coagulans / lipase / protease Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1543728 | amylase / Bacillus coagulans / lipase / protease | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 1543729 | lipase 30,000 UNT / amylase 450 UNT / Bacillus coagulans 1 Billion UNT / protease 450 UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1543729 | lipase 30,000 UNT / amylase 450 UNT / Bacillus coagulans 1 Billion UNT / protease 450 UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543729 | lipase 30,000 UNT / amylase 450 UNT / Bacillus coagulans 1 Billion UNT / protease 450 UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543729 | lipase 30,000 UNT / amylase 450 UNT / Bacillus coagulans 1 Billion UNT / protease 450 UNT Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1543730 | Fallback Solo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1543731 | levonorgestrel 1.5 MG [Fallback Solo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1543732 | levonorgestrel Oral Tablet [Fallback Solo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1543733 | Fallback Solo Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1543734 | Fallback Solo Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1543735 | Fallback Solo 1.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1543735 | Fallback Solo 1.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543735 | Fallback Solo 1.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1543741 | PEG-90 stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1543742 | beef tongue preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1543743 | petrolatum 0.59 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1543744 | petrolatum 59 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1543744 | petrolatum 59 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1543744 | petrolatum 59 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543745 | histamine dihydrochloride 0.35 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1543746 | capsaicin / histamine Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1543747 | capsaicin / histamine Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1543748 | capsaicin / histamine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1543749 | capsaicin 0.375 % / histamine dihydrochloride 0.035 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1543749 | capsaicin 0.375 % / histamine dihydrochloride 0.035 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 154375 | Receptor | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 154375 | Receptor | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1543750 | PainMD Max | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1543751 | capsaicin 0.375 MG/ML / histamine dihydrochloride 0.35 MG/ML [PainMD Max] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1543752 | capsaicin / histamine Topical Cream [PainMD Max] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1543753 | PainMD Max Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1543754 | PainMD Max 0.375 % / 0035 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1543754 | PainMD Max 0.375 % / 0035 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543754 | PainMD Max 0.375 % / 0035 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1543755 | chlorous acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1543758 | influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1543759 | influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 50000000 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1543760 | influenza B virus vaccine, B-Massachusetts-2-2012-like virus 50000000 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1543761 | influenza B virus vaccine B/Brisbane/60/2008 antigen 50000000 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1543762 | influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Inhalant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1543763 | influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Nasal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1543764 | influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Nasal Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1543766 | influenza virus vaccine 2014-2015 formula, quadrivalent, live attentuated Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1543766 | influenza virus vaccine 2014-2015 formula, quadrivalent, live attentuated Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1543766 | influenza virus vaccine 2014-2015 formula, quadrivalent, live attentuated Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543767 | Flumist 2014-2015 Formula | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1543768 | influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 50000000 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 50000000 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 50000000 MG/ML [Flumist 2014-2015 Formula] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1543769 | influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Nasal Spray [Flumist 2014-2015 Formula] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1543770 | Flumist 2014-2015 Formula Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1543771 | Flumist 2014-2015 Formula Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1543772 | FluMist Quadrivalent 2014-2015 Formula Influenza Vaccine, Live Attenuated Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1543772 | FluMist Quadrivalent 2014-2015 Formula Influenza Vaccine, Live Attenuated Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1543772 | FluMist Quadrivalent 2014-2015 Formula Influenza Vaccine, Live Attenuated Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1543773 | PEG-8 caprylic-capric glycerides | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 15438 | 5alpha-hydroxysteroid dehydratase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 15438 | 5alpha-hydroxysteroid dehydratase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 154384 | Reptile venom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 154384 | Reptile venom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1543946 | Acticlate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1543948 | doxycycline Oral Tablet [Acticlate] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1543949 | Acticlate Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1543950 | Acticlate Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1543953 | Acticlate 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1543953 | Acticlate 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543953 | Acticlate 150 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1543955 | Acticlate 75 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1543955 | Acticlate 75 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1543955 | Acticlate 75 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1544064 | lidocaine 50 MG/ML [Lidocream] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1544065 | LidoCream5 5 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1544065 | LidoCream5 5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544065 | LidoCream5 5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544065 | LidoCream5 5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1544124 | Ecamsule | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544124 | Ecamsule | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1544124 | Ecamsule | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1544124 | Ecamsule | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1544124 | Ecamsule | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1544125 | silver fluoride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544128 | Sus scrofa meniscus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544131 | Plectranthus barbatus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544135 | vinylpyrrolidone-eicosene copolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1544136 | Bos taurus conjunctiva preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544137 | Bos taurus lymph vessel preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544139 | carbonate ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1544140 | ferrous disulfide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544178 | povidone-iodine 5 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1544178 | povidone-iodine 5 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544178 | povidone-iodine 5 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1544179 | Pro-Tec Gold | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1544180 | povidone-iodine 50 MG/ML [Pro-Tec Gold] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1544181 | povidone-iodine Medicated Shampoo [Pro-Tec Gold] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1544182 | Pro-Tec Gold Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1544183 | PRO-TEC GOLD 5 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1544183 | PRO-TEC GOLD 5 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1544183 | PRO-TEC GOLD 5 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544183 | PRO-TEC GOLD 5 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544184 | povidone-iodine 100 MG/ML [Pro-Tec Gold] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1544185 | povidone-iodine Topical Solution [Pro-Tec Gold] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1544186 | Pro-Tec Gold Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1544187 | PRO-TEC GOLD 10 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1544187 | PRO-TEC GOLD 10 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1544187 | PRO-TEC GOLD 10 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544187 | PRO-TEC GOLD 10 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544193 | bronopol 2.45 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1544194 | bronopol 0.245 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1544194 | bronopol 0.245 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544194 | bronopol 0.245 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1544245 | Bos taurus somatic nerve preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544246 | Centaurium erythraea flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544247 | Imperatoria ostruthia root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544248 | Myristica fragrans whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 154425 | bran 1000 MG Oral Wafer | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1544270 | Syzygium aromaticum fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544271 | sweet marjoram extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544272 | Anemarrhena asphodeloides whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544273 | Ocimum africanum leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544274 | hydrolyzed sericin (enzymatic; 2500 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544275 | ethyl glutamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544276 | propylene glycol 1-allyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544280 | nitric oxide 0.5 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1544281 | nitric oxide 5000 PPM Gas for Inhalation | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1544281 | nitric oxide 5000 PPM Gas for Inhalation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544281 | nitric oxide 5000 PPM Gas for Inhalation | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1544373 | Renuee | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1544374 | dimethicone 20 MG/ML [Renuee] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1544375 | dimethicone Topical Cream [Renuee] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1544376 | Renuee Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1544377 | Renuee 2 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1544377 | Renuee 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1544377 | Renuee 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544378 | methotrexate 10 MG in 0.2 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1544378 | methotrexate 10 MG in 0.2 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544378 | methotrexate 10 MG in 0.2 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544378 | methotrexate 10 MG in 0.2 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544379 | Rasuvo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1544380 | methotrexate 50 MG/ML [Rasuvo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1544382 | Rasuvo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1544383 | Rasuvo 10 MG in 0.2 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1544383 | Rasuvo 10 MG in 0.2 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544383 | Rasuvo 10 MG in 0.2 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544383 | Rasuvo 10 MG in 0.2 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544383 | Rasuvo 10 MG in 0.2 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544384 | methotrexate 50 MG/ML Auto-Injector [Rasuvo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1544384 | methotrexate 50 MG/ML Auto-Injector [Rasuvo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544384 | methotrexate 50 MG/ML Auto-Injector [Rasuvo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544385 | methotrexate 12.5 MG in 0.25 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1544385 | methotrexate 12.5 MG in 0.25 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544385 | methotrexate 12.5 MG in 0.25 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544385 | methotrexate 12.5 MG in 0.25 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544386 | Rasuvo 12.5 MG in 0.25 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1544386 | Rasuvo 12.5 MG in 0.25 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544386 | Rasuvo 12.5 MG in 0.25 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544386 | Rasuvo 12.5 MG in 0.25 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544386 | Rasuvo 12.5 MG in 0.25 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544387 | methotrexate 15 MG in 0.3 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1544387 | methotrexate 15 MG in 0.3 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544387 | methotrexate 15 MG in 0.3 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544387 | methotrexate 15 MG in 0.3 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544388 | Rasuvo 15 MG in 0.3 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1544388 | Rasuvo 15 MG in 0.3 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544388 | Rasuvo 15 MG in 0.3 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544388 | Rasuvo 15 MG in 0.3 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544388 | Rasuvo 15 MG in 0.3 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544389 | methotrexate 17.5 MG in 0.35 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1544389 | methotrexate 17.5 MG in 0.35 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544389 | methotrexate 17.5 MG in 0.35 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544389 | methotrexate 17.5 MG in 0.35 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544390 | Rasuvo 17.5 MG in 0.35 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1544390 | Rasuvo 17.5 MG in 0.35 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544390 | Rasuvo 17.5 MG in 0.35 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544390 | Rasuvo 17.5 MG in 0.35 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544390 | Rasuvo 17.5 MG in 0.35 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544391 | lead acetate anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1544392 | Epigaea repens extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544393 | D&C orange no. 11 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544394 | Rasuvo 20 MG in 0.4 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1544394 | Rasuvo 20 MG in 0.4 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544394 | Rasuvo 20 MG in 0.4 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544394 | Rasuvo 20 MG in 0.4 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544394 | Rasuvo 20 MG in 0.4 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544395 | methotrexate 22.5 MG in 0.45 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1544395 | methotrexate 22.5 MG in 0.45 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544395 | methotrexate 22.5 MG in 0.45 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544395 | methotrexate 22.5 MG in 0.45 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544396 | Rasuvo 22.5 MG in 0.45 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1544396 | Rasuvo 22.5 MG in 0.45 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544396 | Rasuvo 22.5 MG in 0.45 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544396 | Rasuvo 22.5 MG in 0.45 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544396 | Rasuvo 22.5 MG in 0.45 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544397 | methotrexate 25 MG in 0.5 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1544397 | methotrexate 25 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544397 | methotrexate 25 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544397 | methotrexate 25 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544398 | Rasuvo 25 MG in 0.5 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1544398 | Rasuvo 25 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544398 | Rasuvo 25 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544398 | Rasuvo 25 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544398 | Rasuvo 25 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544399 | methotrexate 27.5 MG in 0.55 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1544399 | methotrexate 27.5 MG in 0.55 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544399 | methotrexate 27.5 MG in 0.55 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1544399 | methotrexate 27.5 MG in 0.55 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544400 | Rasuvo 27.5 MG in 0.55 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1544400 | Rasuvo 27.5 MG in 0.55 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544400 | Rasuvo 27.5 MG in 0.55 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544400 | Rasuvo 27.5 MG in 0.55 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1544400 | Rasuvo 27.5 MG in 0.55 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544401 | methotrexate 30 MG in 0.6 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1544401 | methotrexate 30 MG in 0.6 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544401 | methotrexate 30 MG in 0.6 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544401 | methotrexate 30 MG in 0.6 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544402 | Rasuvo 30 MG in 0.6 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1544402 | Rasuvo 30 MG in 0.6 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544402 | Rasuvo 30 MG in 0.6 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544402 | Rasuvo 30 MG in 0.6 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544402 | Rasuvo 30 MG in 0.6 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544403 | methotrexate 7.5 MG in 0.15 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1544403 | methotrexate 7.5 MG in 0.15 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544403 | methotrexate 7.5 MG in 0.15 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544403 | methotrexate 7.5 MG in 0.15 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544404 | Rasuvo 7.5 MG in 0.15 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1544404 | Rasuvo 7.5 MG in 0.15 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544404 | Rasuvo 7.5 MG in 0.15 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544404 | Rasuvo 7.5 MG in 0.15 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544404 | Rasuvo 7.5 MG in 0.15 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544455 | carprofen 50 MG/ML [Carprieve] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1544456 | carprofen Injectable Solution [Carprieve] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1544457 | Carprieve Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1544458 | carprofen 50 MG/ML Injectable Solution [Carprieve] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544458 | carprofen 50 MG/ML Injectable Solution [Carprieve] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1544460 | idelalisib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1544460 | idelalisib | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1544460 | idelalisib | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1544460 | idelalisib | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1544460 | idelalisib | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1544461 | idelalisib 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1544462 | idelalisib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1544462 | idelalisib Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1544462 | idelalisib Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1544463 | idelalisib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1544464 | idelalisib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1544465 | idelalisib 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544465 | idelalisib 100 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1544465 | idelalisib 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1544465 | idelalisib 100 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1544466 | Zydelig | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1544467 | idelalisib 100 MG [Zydelig] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1544468 | idelalisib Oral Tablet [Zydelig] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1544469 | Zydelig Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1544470 | Zydelig Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1544471 | Zydelig 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1544471 | Zydelig 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544471 | Zydelig 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544472 | idelalisib 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1544473 | idelalisib 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544473 | idelalisib 150 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1544473 | idelalisib 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1544473 | idelalisib 150 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1544474 | idelalisib 150 MG [Zydelig] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1544475 | Zydelig 150 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1544475 | Zydelig 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544475 | Zydelig 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544476 | cocoa butter 0.5 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1544477 | cocoa butter 50 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1544477 | cocoa butter 50 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1544477 | cocoa butter 50 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544483 | bis-PEG-10 dimethicone dimer dilinoleate copolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1544484 | Eichhornia crassipes whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544485 | fumaryl diketopiperazine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1544486 | myreth-4 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544488 | regular insulin, human 8 UNT Inhalation Powder Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1544488 | regular insulin, human 8 UNT Inhalation Powder Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544488 | regular insulin, human 8 UNT Inhalation Powder Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544490 | afrezza 8 UNT Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544490 | afrezza 8 UNT Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544490 | afrezza 8 UNT Inhalation Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1544556 | neomycin sulfate 0.5 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1544556 | neomycin sulfate 0.5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544556 | neomycin sulfate 0.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544556 | neomycin sulfate 0.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544568 | regular insulin 90 Inhalation Powder Pack - 60 (4 UNT), 30 (8 UNT) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| Concept ID (RxCUI): 1544568 | regular insulin 90 Inhalation Powder Pack - 60 (4 UNT), 30 (8 UNT) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1544569 | afrezza 90 Inhalation Cartridge Pack - 60 (4 UNT), 30 (8 UNT) | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| Concept ID (RxCUI): 1544569 | afrezza 90 Inhalation Cartridge Pack - 60 (4 UNT), 30 (8 UNT) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544569 | afrezza 90 Inhalation Cartridge Pack - 60 (4 UNT), 30 (8 UNT) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1544570 | regular insulin, human 90 Inhalation Powder Pack - 30 (4 UNT), 60 (8 UNT) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| Concept ID (RxCUI): 1544570 | regular insulin, human 90 Inhalation Powder Pack - 30 (4 UNT), 60 (8 UNT) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1544571 | afrezza 90 Inhalation Cartridge Pack - 30 (4 UNT), 60 (8 UNT) | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| Concept ID (RxCUI): 1544571 | afrezza 90 Inhalation Cartridge Pack - 30 (4 UNT), 60 (8 UNT) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544571 | afrezza 90 Inhalation Cartridge Pack - 30 (4 UNT), 60 (8 UNT) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1544575 | dilauryldimonium chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544577 | Alphaxolone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544577 | Alphaxolone | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1544577 | Alphaxolone | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1544577 | Alphaxolone | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1544577 | Alphaxolone | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 154462 | Tumor suppressor protein | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 154462 | Tumor suppressor protein | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 154462 | Tumor suppressor protein | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 1544622 | influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1544623 | influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1544624 | influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Flulaval 2014-2015 Formula] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1544625 | influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Flulaval 2014-2015 Formula] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544625 | influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Flulaval 2014-2015 Formula] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1544626 | Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), Inactivated 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1544626 | Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), Inactivated 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544627 | influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Flulaval 2014-2015 Formula] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1544628 | 0.5 ML influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Flulaval 2014-2015 Formula] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1544628 | 0.5 ML influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Flulaval 2014-2015 Formula] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544629 | influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1544630 | influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Flulaval 2014-2015 Formula] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1544631 | influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1544632 | influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Flulaval Quad 2014-2015 Formula] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1544633 | influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Flulaval Quad 2014-2015 Formula] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544633 | influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Flulaval Quad 2014-2015 Formula] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1544634 | Cucurbita pepo flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544637 | lidocaine 4 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1544637 | lidocaine 4 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544637 | lidocaine 4 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1544638 | lidocaine 40 MG/ML [Anestafoam] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1544639 | Anestafoam 4 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1544639 | Anestafoam 4 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544639 | Anestafoam 4 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544639 | Anestafoam 4 % Topical Foam | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1544641 | Omnicide | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1544642 | benzalkonium chloride 0.0013 MG/MG [Omnicide] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1544643 | benzalkonium Topical Gel [Omnicide] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1544644 | Omnicide Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1544645 | Omnicide Antimicrobial 0.13 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1544645 | Omnicide Antimicrobial 0.13 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544645 | Omnicide Antimicrobial 0.13 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544645 | Omnicide Antimicrobial 0.13 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1544707 | urea 400 MG/ML [Rea-Lo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1544708 | rea lo 40 Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544708 | rea lo 40 Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544708 | rea lo 40 Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544708 | rea lo 40 Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1544716 | calamine / pramoxine Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1544717 | calamine 8 % / pramoxine HCl 1 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544717 | calamine 8 % / pramoxine HCl 1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544717 | calamine 8 % / pramoxine HCl 1 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1544718 | urea Topical Lotion [Rea-Lo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1544719 | rea lo 40 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544719 | rea lo 40 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544719 | rea lo 40 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544719 | rea lo 40 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1544753 | dantrolene sodium 250 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544753 | dantrolene sodium 250 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1544754 | Ryanodex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1544757 | Ryanodex Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1544758 | Ryanodex 250 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1544758 | Ryanodex 250 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544758 | Ryanodex 250 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544849 | buprenorphine 4.2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1544850 | naloxone 0.7 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1544851 | buprenorphine 4.2 MG / naloxone 0.7 MG Buccal Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544851 | buprenorphine 4.2 MG / naloxone 0.7 MG Buccal Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1544852 | buprenorphine 4.2 MG / naloxone 0.7 MG [Bunavail] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1544853 | Bunavail 4.2 / 0.7 Buccal Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544853 | Bunavail 4.2 / 0.7 Buccal Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544853 | Bunavail 4.2 / 0.7 Buccal Film | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1544854 | buprenorphine 6.3 MG / naloxone 1 MG Buccal Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544854 | buprenorphine 6.3 MG / naloxone 1 MG Buccal Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1544855 | buprenorphine 6.3 MG / naloxone 1 MG [Bunavail] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1544856 | Bunavail 6.3 / 1 Buccal Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544856 | Bunavail 6.3 / 1 Buccal Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544856 | Bunavail 6.3 / 1 Buccal Film | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1544862 | witch hazel 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1544863 | witch hazel 20 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544863 | witch hazel 20 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544863 | witch hazel 20 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1544873 | dextromethorphan HBr 5 MG / phenylephrine HCl 2.5 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544873 | dextromethorphan HBr 5 MG / phenylephrine HCl 2.5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544873 | dextromethorphan HBr 5 MG / phenylephrine HCl 2.5 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1544907 | Puroxcin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1544910 | Puroxcin Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1544916 | exenatide 2 MG in 0.65 mL Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1544916 | exenatide 2 MG in 0.65 mL Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544916 | exenatide 2 MG in 0.65 mL Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544918 | Byrdureon 2 MG in 0.65 mL Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544918 | Byrdureon 2 MG in 0.65 mL Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1544918 | Byrdureon 2 MG in 0.65 mL Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544918 | Byrdureon 2 MG in 0.65 mL Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544919 | exenatide 3.08 MG/ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1544920 | exenatide 3.08 MG/ML Pen Injector [Bydureon] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544920 | exenatide 3.08 MG/ML Pen Injector [Bydureon] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544920 | exenatide 3.08 MG/ML Pen Injector [Bydureon] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1544923 | Epstein-Barr virus immunoglobulin M early antibody | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1544923 | Epstein-Barr virus immunoglobulin M early antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544923 | Epstein-Barr virus immunoglobulin M early antibody | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1544929 | Enterobacter aerogenes | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544930 | Bartonella bacilliformis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544931 | Bartonella clarridgeiae | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544932 | Bartonella elizabethae | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544933 | Bartonella henselae | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544934 | Bartonella quintana | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544935 | Bartonella vinsonii | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544936 | Bartonella washoensis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544937 | Citrobacter koseri | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 154496 | Transacylase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 154496 | Transacylase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1544967 | 2-butyloctyl methacrylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1544968 | mineral oil 14 % / petrolatum 71.9 % / phenylephrine HCl 0.25 % / shark liver oil preparation 3 % Rectal Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1544968 | mineral oil 14 % / petrolatum 71.9 % / phenylephrine HCl 0.25 % / shark liver oil preparation 3 % Rectal Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1544968 | mineral oil 14 % / petrolatum 71.9 % / phenylephrine HCl 0.25 % / shark liver oil preparation 3 % Rectal Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1544971 | phenylephrine HCl 0.25 % / shark liver oil preparation 3 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1544971 | phenylephrine HCl 0.25 % / shark liver oil preparation 3 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544971 | phenylephrine HCl 0.25 % / shark liver oil preparation 3 % Rectal Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1544972 | phenylephrine hydrochloride 2.5 MG/ML / shark liver oil 30 MG/ML [Formulation R] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1544973 | Formulation R 0.25 % / 3 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1544973 | Formulation R 0.25 % / 3 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1544973 | Formulation R 0.25 % / 3 % Rectal Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 154500 | Hydroxy Compound - Ephedrine, Hydroxyzine & Theophylline | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 154500 | Hydroxy Compound - Ephedrine, Hydroxyzine & Theophylline | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1545020 | orbifloxacin 22.7 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1545021 | orbifloxacin Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1545022 | orbifloxacin Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1545023 | orbifloxacin 22.7 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1545023 | orbifloxacin 22.7 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1545024 | orbifloxacin 22.7 MG [Orbax] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1545025 | orbifloxacin Oral Tablet [Orbax] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1545026 | Orbax Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1545027 | Orbax 22.7 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1545027 | Orbax 22.7 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545027 | Orbax 22.7 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1545028 | orbifloxacin 68 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1545029 | orbifloxacin 68 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1545029 | orbifloxacin 68 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1545030 | orbifloxacin 68 MG [Orbax] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1545031 | Orbax 68 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1545031 | Orbax 68 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545031 | Orbax 68 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1545033 | benzoyl peroxide 4.4 % Medicated Liquid Soap (133 ML) / doxycycline monohydrate 100 MG oral tablet (30) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| Concept ID (RxCUI): 1545033 | benzoyl peroxide 4.4 % Medicated Liquid Soap (133 ML) / doxycycline monohydrate 100 MG oral tablet (30) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1545034 | Benoxyldoxy 30 Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| Concept ID (RxCUI): 1545034 | Benoxyldoxy 30 Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545034 | Benoxyldoxy 30 Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1545035 | benzoyl peroxide 4.4 % Medicated Liquid Soap (133 ML) / doxycycline monohydrate 100 MG oral tablet (60) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| Concept ID (RxCUI): 1545035 | benzoyl peroxide 4.4 % Medicated Liquid Soap (133 ML) / doxycycline monohydrate 100 MG oral tablet (60) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1545036 | Benoxyldoxy 60 Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| Concept ID (RxCUI): 1545036 | Benoxyldoxy 60 Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545036 | Benoxyldoxy 60 Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1545037 | Abies alba leafy twig extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1545038 | Anamirta cocculus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1545039 | Bos taurus colon preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1545040 | poison hemlock root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1545040 | poison hemlock root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545041 | Ovis aries testicle preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1545042 | Verbascum thapsus leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1545043 | lead carbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1545045 | Product containing precisely vemurafenib 240 milligram/1 each conventional release oral capsule (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1545045 | Product containing precisely vemurafenib 240 milligram/1 each conventional release oral capsule (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1545046 | ferric sulfate Oral Gel Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1545047 | ferric sulfate Oral Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1545048 | ferric sulfate 20 % Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1545048 | ferric sulfate 20 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1545048 | ferric sulfate 20 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1545050 | Amfetamine and/or amfetamine derivative | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545050 | Amfetamine and/or amfetamine derivative | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1545050 | Amfetamine and/or amfetamine derivative | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1545051 | Substance with B-Raf inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1545051 | Substance with B-Raf inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1545051 | Substance with B-Raf inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1545051 | Substance with B-Raf inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545051 | Substance with B-Raf inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1545054 | Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1545054 | Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1545054 | Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1545054 | Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545054 | Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1545063 | Tafamidis | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1545063 | Tafamidis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1545063 | Tafamidis | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1545063 | Tafamidis | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1545063 | Tafamidis | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1545065 | tafamidis Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1545065 | tafamidis Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1545065 | tafamidis Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1545066 | tafamidis Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1545067 | tafamidis Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 154509 | Farnesyltransferase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 154509 | Farnesyltransferase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 154509 | Farnesyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 154509 | Farnesyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545142 | colloidal oatmeal 1 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1545142 | colloidal oatmeal 1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1545142 | colloidal oatmeal 1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545143 | phenylephrine / zinc oxide Rectal Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1545144 | phenylephrine HCl 0.25 % / zinc oxide 12.5 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1545144 | phenylephrine HCl 0.25 % / zinc oxide 12.5 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545144 | phenylephrine HCl 0.25 % / zinc oxide 12.5 % Rectal Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1545144 | phenylephrine HCl 0.25 % / zinc oxide 12.5 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545145 | canagliflozin 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1545146 | canagliflozin / metFORMIN Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1545146 | canagliflozin / metFORMIN Oral Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1545146 | canagliflozin / metFORMIN Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1545146 | canagliflozin / metFORMIN Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1545147 | canagliflozin / metFORMIN Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1545147 | canagliflozin / metFORMIN Pill | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1545148 | canagliflozin / metFORMIN Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1545148 | canagliflozin / metFORMIN Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1545149 | canagliflozin / metFORMIN | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 1545149 | canagliflozin / metFORMIN | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1545149 | canagliflozin / metFORMIN | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1545149 | canagliflozin / metFORMIN | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1545150 | canagliflozin 150 MG / metFORMIN HCl 1000 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1545150 | canagliflozin 150 MG / metFORMIN HCl 1000 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1545150 | canagliflozin 150 MG / metFORMIN HCl 1000 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1545151 | Invokamet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1545152 | canagliflozin 150 MG / metFORMIN hydrochloride 1000 MG [Invokamet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1545152 | canagliflozin 150 MG / metFORMIN hydrochloride 1000 MG [Invokamet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1545153 | canagliflozin / metFORMIN Oral Tablet [Invokamet] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1545153 | canagliflozin / metFORMIN Oral Tablet [Invokamet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1545154 | Invokamet Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1545155 | Invokamet Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1545156 | Invokamet 150 MG / 1000 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1545156 | Invokamet 150 MG / 1000 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1545156 | Invokamet 150 MG / 1000 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1545156 | Invokamet 150 MG / 1000 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1545156 | Invokamet 150 MG / 1000 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1545157 | canagliflozin 150 MG / metFORMIN HCl 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1545157 | canagliflozin 150 MG / metFORMIN HCl 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1545157 | canagliflozin 150 MG / metFORMIN HCl 500 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1545158 | canagliflozin 150 MG / metFORMIN hydrochloride 500 MG [Invokamet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1545158 | canagliflozin 150 MG / metFORMIN hydrochloride 500 MG [Invokamet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1545159 | Invokamet 150 MG / 500 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1545159 | Invokamet 150 MG / 500 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1545159 | Invokamet 150 MG / 500 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1545159 | Invokamet 150 MG / 500 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1545159 | Invokamet 150 MG / 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1545160 | canagliflozin 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1545161 | canagliflozin 50 MG / metFORMIN HCl 1000 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1545161 | canagliflozin 50 MG / metFORMIN HCl 1000 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1545161 | canagliflozin 50 MG / metFORMIN HCl 1000 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1545162 | canagliflozin 50 MG / metFORMIN hydrochloride 1000 MG [Invokamet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1545162 | canagliflozin 50 MG / metFORMIN hydrochloride 1000 MG [Invokamet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1545163 | Invokamet 50 MG / 1000 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1545163 | Invokamet 50 MG / 1000 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1545163 | Invokamet 50 MG / 1000 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1545163 | Invokamet 50 MG / 1000 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1545163 | Invokamet 50 MG / 1000 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1545164 | canagliflozin 50 MG / metFORMIN HCl 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1545164 | canagliflozin 50 MG / metFORMIN HCl 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1545164 | canagliflozin 50 MG / metFORMIN HCl 500 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1545165 | canagliflozin 50 MG / metFORMIN hydrochloride 500 MG [Invokamet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1545165 | canagliflozin 50 MG / metFORMIN hydrochloride 500 MG [Invokamet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1545166 | Invokamet 50 MG / 500 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1545166 | Invokamet 50 MG / 500 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1545166 | Invokamet 50 MG / 500 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1545166 | Invokamet 50 MG / 500 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1545166 | Invokamet 50 MG / 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1545167 | N-tert-octylacrylamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1545168 | ceteareth-2 phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1545169 | ceteareth-2 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1545170 | Apis cerana whole preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1545171 | hydrocortisone acetate 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1545172 | hydrocortisone acetate 10 % Rectal Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1545172 | hydrocortisone acetate 10 % Rectal Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1545172 | hydrocortisone acetate 10 % Rectal Foam | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1545172 | hydrocortisone acetate 10 % Rectal Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1545172 | hydrocortisone acetate 10 % Rectal Foam | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1545173 | hydrocortisone acetate 100 MG/ML [Cortifoam] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1545174 | cortifoam 10 % Rectal Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1545174 | cortifoam 10 % Rectal Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1545174 | cortifoam 10 % Rectal Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1545174 | cortifoam 10 % Rectal Foam | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1545290 | lidocaine HCl 5 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1545290 | lidocaine HCl 5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545290 | lidocaine HCl 5 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1545291 | lidocaine hydrochloride 50 MG/ML [Derma Numb] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1545292 | Derma Numb 5 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1545292 | Derma Numb 5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545292 | Derma Numb 5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545292 | Derma Numb 5 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1545293 | menthol 1.25 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1545293 | menthol 1.25 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545293 | menthol 1.25 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1545294 | lidocaine hydrochloride 24.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1545295 | lidocaine HCl 2.46 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1545295 | lidocaine HCl 2.46 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1545296 | lidocaine hydrochloride 24.6 MG/ML [Hexa-Caine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1545297 | Hexa-Caine Anti-Itch 2.46 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545297 | Hexa-Caine Anti-Itch 2.46 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545297 | Hexa-Caine Anti-Itch 2.46 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1545297 | Hexa-Caine Anti-Itch 2.46 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1545298 | Afterpill | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1545299 | levonorgestrel 1.5 MG [Afterpill] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1545300 | levonorgestrel Oral Tablet [Afterpill] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1545301 | Afterpill Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1545302 | Afterpill Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1545303 | AfterPill 1.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1545303 | AfterPill 1.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1545303 | AfterPill 1.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1545304 | dexbrompheniramine Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1545305 | dexbrompheniramine Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1545306 | dexbrompheniramine maleate 1 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1545306 | dexbrompheniramine maleate 1 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1545307 | dexbrompheniramine Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1545308 | dexbrompheniramine Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1545309 | dexbrompheniramine maleate 2 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1545309 | dexbrompheniramine maleate 2 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1545309 | dexbrompheniramine maleate 2 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1545358 | PEG-20 glyceryl triisostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 154558 | Beta-lactamase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 154558 | Beta-lactamase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1545650 | simethicone Chewable Tablet [Dulcogas] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1545651 | Dulcogas Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1545652 | Dulcogas 125 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1545652 | Dulcogas 125 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545652 | Dulcogas 125 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1545653 | empagliflozin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1545653 | empagliflozin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1545653 | empagliflozin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1545653 | empagliflozin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1545653 | empagliflozin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1545654 | empagliflozin 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1545655 | empagliflozin Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1545655 | empagliflozin Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1545655 | empagliflozin Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1545656 | empagliflozin Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1545657 | empagliflozin Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1545658 | empagliflozin 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1545658 | empagliflozin 10 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1545658 | empagliflozin 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1545658 | empagliflozin 10 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1545659 | Jardiance | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1545660 | empagliflozin 10 MG [Jardiance] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1545661 | empagliflozin Oral Tablet [Jardiance] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1545662 | Jardiance Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1545663 | Jardiance Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1545664 | Jardiance 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1545664 | Jardiance 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1545664 | Jardiance 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1545665 | empagliflozin 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1545666 | empagliflozin 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1545666 | empagliflozin 25 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1545666 | empagliflozin 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1545666 | empagliflozin 25 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1545667 | empagliflozin 25 MG [Jardiance] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1545668 | Jardiance 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1545668 | Jardiance 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1545668 | Jardiance 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1545669 | phenylephrine HCl 0.25 % / shark liver oil 3 % Rectal Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1545669 | phenylephrine HCl 0.25 % / shark liver oil 3 % Rectal Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1545669 | phenylephrine HCl 0.25 % / shark liver oil 3 % Rectal Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545671 | benzalkonium Topical Foam [Veteran Shield 24] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1545672 | Veteran Shield 24 Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1545673 | Veteran Shield 24 0.1 % Topical Foam | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1545673 | Veteran Shield 24 0.1 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1545673 | Veteran Shield 24 0.1 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545673 | Veteran Shield 24 0.1 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545674 | Elta Seal Moisture Barrier | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1545675 | zinc oxide 60 MG/ML [Elta Seal Moisture Barrier] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1545676 | zinc oxide Topical Cream [Elta Seal Moisture Barrier] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1545677 | Elta Seal Moisture Barrier Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1545678 | Elta Seal Moisture Barrier 6 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1545678 | Elta Seal Moisture Barrier 6 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545678 | Elta Seal Moisture Barrier 6 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1545678 | Elta Seal Moisture Barrier 6 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545680 | Cervus elaphus whole preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1545681 | Cichorium intybus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1545682 | Colchicum autumnale whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1545683 | Krameria lappacea whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1545684 | Ononis repens root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1545685 | phenyl butyrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1545687 | benzalkonium / lidocaine Topical Spray [Bactine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1545688 | Bactine 0.13 % / 2.5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545688 | Bactine 0.13 % / 2.5 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1545688 | Bactine 0.13 % / 2.5 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 15457 | Cytokinin synthase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 15457 | Cytokinin synthase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 15457 | Cytokinin synthase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545702 | capsaicin 1.5 MG/ML [Capzasin-P] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1545703 | Capzasin-P 0.15 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1545703 | Capzasin-P 0.15 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1545703 | Capzasin-P 0.15 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545703 | Capzasin-P 0.15 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545708 | methylprednisolone acetate 40 ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1545708 | methylprednisolone acetate 40 ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1545709 | methylprednisolone acetate 40 ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1545709 | methylprednisolone acetate 40 ML Injectable Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1545711 | methylprednisolone acetate 40 ML [Depo-Medrol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1545711 | methylprednisolone acetate 40 ML [Depo-Medrol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1545712 | methylprednisolone acetate 40 ML Injectable Suspension [Depo-Medrol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545712 | methylprednisolone acetate 40 ML Injectable Suspension [Depo-Medrol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1545712 | methylprednisolone acetate 40 ML Injectable Suspension [Depo-Medrol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1545712 | methylprednisolone acetate 40 ML Injectable Suspension [Depo-Medrol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1545716 | benzethonium Cl 0.2 % / lidocaine 4 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1545716 | benzethonium Cl 0.2 % / lidocaine 4 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1545716 | benzethonium Cl 0.2 % / lidocaine 4 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1545771 | Gleostine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1545772 | lomustine 10 MG [Gleostine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1545773 | lomustine Oral Capsule [Gleostine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1545774 | Gleostine Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1545775 | Gleostine Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1545776 | Gleostine 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1545776 | Gleostine 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1545776 | Gleostine 10 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1545777 | lomustine 100 MG [Gleostine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1545778 | Gleostine 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1545778 | Gleostine 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1545778 | Gleostine 100 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1545779 | lomustine 40 MG [Gleostine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1545780 | Gleostine 40 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1545780 | Gleostine 40 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1545780 | Gleostine 40 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1545787 | benzalkonium chloride 0.13 % / benzocaine 7.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1545787 | benzalkonium chloride 0.13 % / benzocaine 7.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545787 | benzalkonium chloride 0.13 % / benzocaine 7.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1545788 | benzalkonium chloride 1.3 MG/ML / benzocaine 75 MG/ML [Viroxyn] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1545789 | benzalkonium chloride 1.3 MG/ML / benzocaine 75 MG/ML Topical Solution [Viroxyn] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1545789 | benzalkonium chloride 1.3 MG/ML / benzocaine 75 MG/ML Topical Solution [Viroxyn] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545790 | Daphne mezereum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1545791 | Populus tremula whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1545792 | chrysosplenetin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1545794 | carbon dioxide 7 % / oxygen 33 % Gas for Inhalation | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1545794 | carbon dioxide 7 % / oxygen 33 % Gas for Inhalation | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1545800 | castor oil 788 MG/ML / Peruvian balsam 87 MG/ML / trypsin 0.12 MG/ML [Granulex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1545801 | Granulex (0.12 MG / 87 MG / 788 MG) per GM Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1545801 | Granulex (0.12 MG / 87 MG / 788 MG) per GM Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1545801 | Granulex (0.12 MG / 87 MG / 788 MG) per GM Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545898 | naloxone hydrochloride 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1545899 | Naloxone- and oxycodone-containing product in oral dose form | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1545899 | Naloxone- and oxycodone-containing product in oral dose form | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1545899 | Naloxone- and oxycodone-containing product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1545899 | Naloxone- and oxycodone-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1545900 | naloxone / oxycodone Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1545900 | naloxone / oxycodone Pill | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1545901 | naloxone / oxycodone Extended Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1545901 | naloxone / oxycodone Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1545902 | Product containing naloxone and oxycodone (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 1545902 | Product containing naloxone and oxycodone (medicinal product) | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1545902 | Product containing naloxone and oxycodone (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1545902 | Product containing naloxone and oxycodone (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1545903 | oxycodone HCl 20 MG / naloxone HCl 10 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1545903 | oxycodone HCl 20 MG / naloxone HCl 10 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1545903 | oxycodone HCl 20 MG / naloxone HCl 10 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545903 | oxycodone HCl 20 MG / naloxone HCl 10 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1545904 | naloxone hydrochloride 10 MG / oxycodone hydrochloride 20 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1545904 | naloxone hydrochloride 10 MG / oxycodone hydrochloride 20 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1545906 | naloxone hydrochloride 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1545907 | oxycodone HCl 40 MG / naloxone HCl 20 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1545907 | oxycodone HCl 40 MG / naloxone HCl 20 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1545907 | oxycodone HCl 40 MG / naloxone HCl 20 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545907 | oxycodone HCl 40 MG / naloxone HCl 20 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1545908 | naloxone hydrochloride 20 MG / oxycodone hydrochloride 40 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1545908 | naloxone hydrochloride 20 MG / oxycodone hydrochloride 40 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1545909 | naloxone hydrochloride 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1545910 | naloxone HCl 5 MG / oxyCODONE HCl 10 MG 12 HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1545910 | naloxone HCl 5 MG / oxyCODONE HCl 10 MG 12 HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1545910 | naloxone HCl 5 MG / oxyCODONE HCl 10 MG 12 HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545910 | naloxone HCl 5 MG / oxyCODONE HCl 10 MG 12 HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1545911 | naloxone hydrochloride 5 MG / oxycodone hydrochloride 10 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1545911 | naloxone hydrochloride 5 MG / oxycodone hydrochloride 10 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1545912 | Sedum roseum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1545918 | dimethicone 1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1545918 | dimethicone 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1545918 | dimethicone 1 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1545975 | cefadroxil anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1545975 | cefadroxil anhydrous | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1545975 | cefadroxil anhydrous | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1545976 | codeine anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1545982 | carbidopa anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1545982 | carbidopa anhydrous | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1545982 | carbidopa anhydrous | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1545984 | ceftazidime anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1545984 | ceftazidime anhydrous | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1545984 | ceftazidime anhydrous | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1545984 | ceftazidime anhydrous | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1545986 | Imipenem anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1545986 | Imipenem anhydrous | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1545986 | Imipenem anhydrous | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1545987 | ethiofos anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1545987 | ethiofos anhydrous | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1545988 | cyclophosphamide anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1545988 | cyclophosphamide anhydrous | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1545988 | cyclophosphamide anhydrous | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1545988 | cyclophosphamide anhydrous | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1545989 | enalaprilat anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1545992 | doxycycline anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1545992 | doxycycline anhydrous | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1545992 | doxycycline anhydrous | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1545996 | Anhydrous methyldopa | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1545996 | Anhydrous methyldopa | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1545996 | Anhydrous methyldopa | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1545996 | Anhydrous methyldopa | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1545999 | oxytetracycline anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1545999 | oxytetracycline anhydrous | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1545999 | oxytetracycline anhydrous | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1546000 | Piperacillin anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1546000 | Piperacillin anhydrous | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1546000 | Piperacillin anhydrous | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1546004 | timolol anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1546005 | thioguanine anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1546007 | cidofovir anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1546009 | levofloxacin anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1546009 | levofloxacin anhydrous | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1546009 | levofloxacin anhydrous | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1546009 | levofloxacin anhydrous | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1546014 | zoledronic acid anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1546014 | zoledronic acid anhydrous | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1546014 | zoledronic acid anhydrous | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1546015 | regadenoson anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1546017 | tenofovir anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1546019 | dasatinib anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1546019 | dasatinib anhydrous | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1546019 | dasatinib anhydrous | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1546020 | cefprozil anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1546021 | Cefixime anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1546021 | Cefixime anhydrous | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1546021 | Cefixime anhydrous | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1546022 | lisinopril anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1546022 | lisinopril anhydrous | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1546022 | lisinopril anhydrous | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1546024 | indinavir anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1546025 | gatifloxacin anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1546027 | entecavir anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1546027 | entecavir anhydrous | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1546027 | entecavir anhydrous | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1546028 | mercaptopurine anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1546029 | meropenem anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1546029 | meropenem anhydrous | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1546029 | meropenem anhydrous | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1546030 | saxagliptin anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1546030 | saxagliptin anhydrous | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 1546031 | canagliflozin anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1546031 | canagliflozin anhydrous | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1546031 | canagliflozin anhydrous | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1546032 | hexylcaine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1546033 | hexylcaine hydrochloride 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1546034 | hexylcaine HCl 5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1546034 | hexylcaine HCl 5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546034 | hexylcaine HCl 5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1546035 | tetracaine hydrochloride 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1546036 | tetracaine HCl 0.5 % Topical Solution | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1546036 | tetracaine HCl 0.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1546036 | tetracaine HCl 0.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546036 | tetracaine HCl 0.5 % Topical Solution | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1546036 | tetracaine HCl 0.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1546037 | tetracycline hydrochloride 2.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1546038 | tetracycline HCl 2.2 MG/ML Topical Solution | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1546038 | tetracycline HCl 2.2 MG/ML Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1546038 | tetracycline HCl 2.2 MG/ML Topical Solution | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1546038 | tetracycline HCl 2.2 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1546039 | tetracycline hydrochloride 2.2 MG/ML [Topicycline] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1546040 | Topicycline 2.2 MG/ML Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1546040 | Topicycline 2.2 MG/ML Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1546050 | furosemide 12.5 MG [Disal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1546051 | furosemide Oral Tablet [Disal] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1546052 | Disal Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1546053 | Disal Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1546054 | Disal 12.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1546054 | Disal 12.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546054 | Disal 12.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1546055 | furosemide 50 MG [Disal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1546056 | Disal 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1546056 | Disal 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546056 | Disal 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1546059 | olodaterol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1546059 | olodaterol | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1546059 | olodaterol | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1546059 | olodaterol | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1546059 | olodaterol | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1546061 | olodaterol Inhalant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1546061 | olodaterol Inhalant Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1546061 | olodaterol Inhalant Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1546064 | Striverdi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1546067 | Striverdi Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1546073 | lidocaine hydrochloride 45 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1546074 | lidocaine HCl 4.5 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1546074 | lidocaine HCl 4.5 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546074 | lidocaine HCl 4.5 % Rectal Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1546076 | olodaterol 0.0025 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1546077 | olodaterol 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 28 ACTUAT | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1546077 | olodaterol 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 28 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546077 | olodaterol 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 28 ACTUAT | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1546078 | olodaterol 0.0025 MG/ACTUAT [Striverdi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1546079 | Striverdi Respimat 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 28 ACTUAT | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1546079 | Striverdi Respimat 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 28 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546079 | Striverdi Respimat 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 28 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546079 | Striverdi Respimat 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 28 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546079 | Striverdi Respimat 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 28 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546079 | Striverdi Respimat 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 28 ACTUAT | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1546080 | olodaterol 0.0025 MG/ACTUAT Metered Dose Inhalation Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1546080 | olodaterol 0.0025 MG/ACTUAT Metered Dose Inhalation Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546081 | olodaterol 0.0025 MG/ACTUAT Inhalation Spray [Striverdi] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1546081 | olodaterol 0.0025 MG/ACTUAT Inhalation Spray [Striverdi] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546081 | olodaterol 0.0025 MG/ACTUAT Inhalation Spray [Striverdi] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546081 | olodaterol 0.0025 MG/ACTUAT Inhalation Spray [Striverdi] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546082 | olodaterol 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 60 ACTUAT | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1546082 | olodaterol 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 60 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1546082 | olodaterol 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 60 ACTUAT | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1546083 | Striverdi Respimat 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 60 ACTUAT | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1546083 | Striverdi Respimat 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 60 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1546083 | Striverdi Respimat 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 60 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1546083 | Striverdi Respimat 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 60 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1546083 | Striverdi Respimat 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 60 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1546083 | Striverdi Respimat 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 60 ACTUAT | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1546084 | Targiniq | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 1546085 | naloxone hydrochloride 5 MG / oxycodone hydrochloride 10 MG [Targiniq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1546085 | naloxone hydrochloride 5 MG / oxycodone hydrochloride 10 MG [Targiniq] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1546086 | naloxone / oxycodone Extended Release Oral Tablet [Targiniq] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1546086 | naloxone / oxycodone Extended Release Oral Tablet [Targiniq] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1546087 | Targiniq Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1546088 | Targiniq Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 1546089 | Targiniq 10 MG / 5 MG 12HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1546089 | Targiniq 10 MG / 5 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1546089 | Targiniq 10 MG / 5 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546089 | Targiniq 10 MG / 5 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1546090 | naloxone hydrochloride 5 MG / oxycodone hydrochloride 10 MG Extended Release Oral Tablet [Targiniq] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1546090 | naloxone hydrochloride 5 MG / oxycodone hydrochloride 10 MG Extended Release Oral Tablet [Targiniq] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1546093 | 0.5 ML influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1546094 | influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Flulaval Quad 2014-2015 Formula] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1546095 | 0.5 ML influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Flulaval Quad 2014-2015 Formula] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1546095 | 0.5 ML influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Flulaval Quad 2014-2015 Formula] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546096 | influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1546097 | influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Flulaval Quad 2014-2015 Formula] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1546102 | camphor 0.2 % / menthol 4 % / methyl salicylate 12.5 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1546102 | camphor 0.2 % / menthol 4 % / methyl salicylate 12.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1546102 | camphor 0.2 % / menthol 4 % / methyl salicylate 12.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 154614 | Dihydroxyphenylalanine decarboxylase inhibitor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 154614 | Dihydroxyphenylalanine decarboxylase inhibitor | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 154614 | Dihydroxyphenylalanine decarboxylase inhibitor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 154614 | Dihydroxyphenylalanine decarboxylase inhibitor | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1546161 | alanine, DL- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1546162 | aluminum cation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1546163 | ivermectin 5 MG/ML [Bimectin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 1546164 | Bimectin Pour-On 5 MG/ML Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1546164 | Bimectin Pour-On 5 MG/ML Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546164 | Bimectin Pour-On 5 MG/ML Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1546165 | amprolium ion | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1546166 | aprolium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1546167 | antimony cation (3+) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1546168 | peginterferon beta-1a | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1546168 | peginterferon beta-1a | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1546168 | peginterferon beta-1a | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1546168 | peginterferon beta-1a | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1546168 | peginterferon beta-1a | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1546169 | peginterferon beta-1a 0.188 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1546170 | peginterferon beta-1a Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 1546170 | peginterferon beta-1a Injectable Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1546170 | peginterferon beta-1a Injectable Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1546171 | peginterferon beta-1a Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 1546172 | peginterferon beta-1a 94 MCG in 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1546172 | peginterferon beta-1a 94 MCG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1546172 | peginterferon beta-1a 94 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1546173 | Plegridy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 1546174 | peginterferon beta-1a 0.188 MG/ML [Plegridy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1546175 | peginterferon beta-1a Prefilled Syringe [Plegridy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1546176 | Plegridy Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 1546177 | Plegridy 94 MCG in 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1546177 | Plegridy 94 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1546177 | Plegridy 94 MCG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1546177 | Plegridy 94 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1546178 | peginterferon beta-1a 0.188 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1546179 | peginterferon beta-1a 0.188 MG/ML Prefilled Syringe [Plegridy] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1546179 | peginterferon beta-1a 0.188 MG/ML Prefilled Syringe [Plegridy] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546180 | peginterferon beta-1a 0.126 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1546181 | peginterferon beta-1a 63 MCG in 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1546181 | peginterferon beta-1a 63 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1546181 | peginterferon beta-1a 63 MCG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1546181 | peginterferon beta-1a 63 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1546182 | peginterferon beta-1a 0.126 MG/ML [Plegridy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1546183 | Plegridy 63 MCG in 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1546183 | Plegridy 63 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1546183 | Plegridy 63 MCG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1546183 | Plegridy 63 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1546184 | peginterferon beta-1a 0.126 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1546185 | peginterferon beta-1a 0.126 MG/ML Prefilled Syringe [Plegridy] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1546185 | peginterferon beta-1a 0.126 MG/ML Prefilled Syringe [Plegridy] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546186 | peginterferon beta-1a 0.25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1546187 | peginterferon beta-1a 125 MCG in 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1546187 | peginterferon beta-1a 125 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1546187 | peginterferon beta-1a 125 MCG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1546187 | peginterferon beta-1a 125 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1546188 | peginterferon beta-1a 0.25 MG/ML [Plegridy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1546189 | Plegridy 125 MCG in 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 1546189 | Plegridy 125 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1546189 | Plegridy 125 MCG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1546189 | Plegridy 125 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1546190 | peginterferon beta-1a 0.25 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1546191 | peginterferon beta-1a 0.25 MG/ML Prefilled Syringe [Plegridy] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1546191 | peginterferon beta-1a 0.25 MG/ML Prefilled Syringe [Plegridy] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546194 | gentamicin sulfate 3 MG / betamethasone valerate 1 MG in 1 ML Otic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1546194 | gentamicin sulfate 3 MG / betamethasone valerate 1 MG in 1 ML Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546194 | gentamicin sulfate 3 MG / betamethasone valerate 1 MG in 1 ML Otic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1546195 | ivermectin 10 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1546196 | benazeprilat | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1546197 | peginterferon beta-1a 63 MCG in 0.5 ML (1) Prefilled Syringe / peginterferon beta-1a 94 MCG in 0.5 ML (1) Prefilled Syringe Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 1546197 | peginterferon beta-1a 63 MCG in 0.5 ML (1) Prefilled Syringe / peginterferon beta-1a 94 MCG in 0.5 ML (1) Prefilled Syringe Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1546198 | Plegridy Starter Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 1546198 | Plegridy Starter Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1546198 | Plegridy Starter Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1546201 | hydrogen peroxide / lactate Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1546202 | hydrogen peroxide 0.5 % / lactic acid 1.7 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1546202 | hydrogen peroxide 0.5 % / lactic acid 1.7 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546202 | hydrogen peroxide 0.5 % / lactic acid 1.7 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1546203 | hydrogen peroxide / lactate Topical Spray [Astri-UC] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1546204 | ASTRI-UC 0.5 % / 1.7 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546204 | ASTRI-UC 0.5 % / 1.7 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1546204 | ASTRI-UC 0.5 % / 1.7 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1546205 | Hirudin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1546205 | Hirudin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1546205 | Hirudin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1546206 | Croton tiglium whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1546207 | argatroban anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1546207 | argatroban anhydrous | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 1546207 | argatroban anhydrous | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1546208 | barium citrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1546209 | ethyl methylphenylglycidate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1546210 | gold monosulfide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1546211 | povidone-iodine 7.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1546212 | povidone-iodine 0.75 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 1546212 | povidone-iodine 0.75 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1546212 | povidone-iodine 0.75 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 1546217 | EPINEPHrine 0.22 MG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1546217 | EPINEPHrine 0.22 MG Inhalation Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1546217 | EPINEPHrine 0.22 MG Inhalation Powder | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 1546223 | diatrizoic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1546231 | carbamide peroxide Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1546232 | carbamide peroxide 15 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1546232 | carbamide peroxide 15 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546232 | carbamide peroxide 15 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1546238 | sodium monofluorophosphate 0.88 % Toothpaste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1546238 | sodium monofluorophosphate 0.88 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546238 | sodium monofluorophosphate 0.88 % Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1546238 | sodium monofluorophosphate 0.88 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546239 | sodium fluoride 0.011 MG/MG [FluoriSHIELD] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 154624 | Substance with topoisomerase inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 154624 | Substance with topoisomerase inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 154624 | Substance with topoisomerase inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 154624 | Substance with topoisomerase inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 154624 | Substance with topoisomerase inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1546240 | sodium fluoride 0.011 MG/MG Oral Gel [FluoriSHIELD] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546240 | sodium fluoride 0.011 MG/MG Oral Gel [FluoriSHIELD] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546240 | sodium fluoride 0.011 MG/MG Oral Gel [FluoriSHIELD] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1546249 | menthol 35 MG/ML [DynaFreeze] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 154625 | Inhalant | Dose Form (DF) | NO | |
| Concept ID (RxCUI): 1546250 | dynaFREEZE 3.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1546250 | dynaFREEZE 3.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546250 | dynaFREEZE 3.5 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1546253 | testosterone 12.5 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 1546254 | testosterone 12.5 MG/ACTUAT Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1546255 | testosterone 12.5 MG/ACTUAT [Vogelxo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 1546256 | testosterone 12.5 MG/ACTUAT Topical Gel [Vogelxo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1546256 | testosterone 12.5 MG/ACTUAT Topical Gel [Vogelxo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546256 | testosterone 12.5 MG/ACTUAT Topical Gel [Vogelxo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546256 | testosterone 12.5 MG/ACTUAT Topical Gel [Vogelxo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546258 | Venous plasma | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1546258 | Venous plasma | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1546264 | zinc cation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1546265 | lithium cation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1546266 | iodide I-125 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1546268 | thiamine ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1546269 | uranium cation (6+) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 154627 | Pancreatic elastase II | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 154627 | Pancreatic elastase II | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1546270 | radium cation | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1546271 | nitrate ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1546272 | manganese cation (2+) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1546273 | fluoride ion F-18 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1546274 | bromide ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1546275 | iodide ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1546276 | cadmium cation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1546277 | bicarbonate ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1546278 | strontium cation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1546279 | oseltamivir acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 1546279 | oseltamivir acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1546280 | nickel cation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1546281 | indium cation In-111 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 1546282 | gallium cation | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1546283 | antimony cation (5+) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1546284 | bismuth cation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1546288 | GentaCalm 0.057 % / 0.0284 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 1546288 | GentaCalm 0.057 % / 0.0284 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546288 | GentaCalm 0.057 % / 0.0284 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1546324 | Pseudonaja textilis antivenom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1546324 | Pseudonaja textilis antivenom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546324 | Pseudonaja textilis antivenom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1546329 | dienogest Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1546329 | dienogest Oral Product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1546329 | dienogest Oral Product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1546330 | dienogest Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 1546331 | dienogest Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 1546332 | dienogest 2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1546332 | dienogest 2 MG Oral Tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1546332 | dienogest 2 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1546332 | dienogest 2 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1546337 | Pseudechis australis antivenom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1546337 | Pseudechis australis antivenom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546337 | Pseudechis australis antivenom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1546339 | Pholcodine citrate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1546339 | Pholcodine citrate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1546341 | Piperilate ethobromide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 1546341 | Piperilate ethobromide | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1546341 | Piperilate ethobromide | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1546349 | ulipristal acetate 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 1546350 | ulipristal acetate 5 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1546350 | ulipristal acetate 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 1546350 | ulipristal acetate 5 MG Oral Tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1546350 | ulipristal acetate 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 1546351 | 1,2-dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (sodium salt) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 1546352 | 2,3-dimercapto-1-propanesulfonic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1546353 | 2-ethylhexyl 4-phenylbenzophenone-2'-carboxylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1546354 | 2-mercaptoethanesulfonic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 1546355 | 4,4'-dinitrocarbanilide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 1546356 | Dabigatran | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). |